0000000001309369

AUTHOR

Stephan Grabbe

showing 134 related works from this author

Dermatology Life Quality Index among Different Cultures: A Neglected Bias Needs to Be Addressed.

2021

GerontologyPsychometricsbusiness.industrySurveys and QuestionnairesQuality of LifeMedicineHumansDermatology Life Quality IndexDermatologybusinessDermatology (Basel, Switzerland)
researchProduct

Treatment options for leishmaniasis.

2021

Leishmaniasis is broadly classified into three types: cutaneous, mucocutaneous and visceral. The visceral form is most dangerous and can result in death. Although leishmaniasis is an ancient disease, its treatment is still challenging. Several drugs, differing in their cost, toxicity, treatment duration and emergence of drug resistance, are used for different types of leishmaniasis. To overcome these limitations, the search for newer drugs and other treatments continues. In this article, we discuss conventional drugs, other treatments, including newer options such as immunotherapy and immunochemotherapy, and future prospects for leishmaniasis treatment.

medicine.medical_specialtyHot Temperaturemedicine.medical_treatmentTreatment durationMucocutaneous zone610 MedizinAntiprotozoal AgentsDermatologyDiseaseDrug resistance610 Medical sciencesmedicineHumansLeishmaniasisbusiness.industryTreatment optionsLeishmaniasisImmunotherapymedicine.diseaseDermatologyCombined Modality TherapyPhotochemotherapyCryotherapyDrug Therapy CombinationImmunotherapybusinessClinical and experimental dermatologyReferences
researchProduct

Significance of the pulsed dye laser in treatment of acral infantile hemangioma

2021

medicine.medical_specialtySkin NeoplasmsDye laserbusiness.industryInfantLasers DyeDermatologyPropranololDermatologyInfantile hemangiomaHumansMedicineLaser TherapyHemangiomabusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?

2009

Myeloid dendritic cells (DC) are "sentinels" of immunity, ideally positioned throughout the body gateways and equipped with unique properties to transport antigens from the periphery to lymphoid tissues. They are professional antigen-presenting cells transmitting incoming infectious signals to T cells, the key players of adaptive immunity. For induction of effective antigen-specific T-cell immunity, crosstalk of DC and naive T cells is mandatory. However, besides this essential immunostimulatory function of DC, consolidated findings from the DC research field in the last 10 years have shown that DC have an additional important function. They act as pivotal players in the peripheral toleranc…

MyeloidImmunologyCell CommunicationBiologyImmune toleranceMiceImmune systemAntigenImmunityT-Lymphocyte SubsetsmedicineImmune ToleranceImmunology and AllergyAnimalsHumansMyeloid CellsImmunologic SurveillancePeripheral toleranceGeneral MedicineDendritic CellsAcquired immune systemCrosstalk (biology)medicine.anatomical_structureImmunity ActiveImmunologyCytokinesHuman immunology
researchProduct

Abstract A004: Systemic RNA vaccines: Connecting effective cancer immunotherapy with antiviral defense mechanisms

2016

Abstract Mechanisms of antiviral host defense are important for survival and evolutionarily optimized for high sensitivity and potency. Intending to harvest the multitude of highly specialized and intertwined pathogen immune defense programs for cancer immunotherapy, we simulated a systemic pathogen intrusion into the blood stream by intravenous injection of lipid-formulated, tumor antigen-encoding mRNA nanoparticles. These RNA-lipoplexes (RNA-LPX) were directed to various lymphoid tissues, including the spleen, lymph nodes and bone marrow, which provide the ideal microenvironment for efficient priming and amplification of T cell responses. Solely the RNA-to-lipid ratio was discovered to de…

Cancer ResearchInnate immune systemmedicine.medical_treatmentT cellImmunologyTLR7Biologymedicine.anatomical_structureCancer immunotherapyAntigenImmunologymedicineCytotoxic T cellAntigen-presenting cellCD8Cancer Immunology Research
researchProduct

Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation

2018

Therapeutic vaccination is and remains a major challenge, particularly in cancer treatment. In this process, the effective activation of dendritic cells by a combination of distinctly acting adjuvants and an antigen is crucial for success. While most common vaccine formulations lack the efficiency to trigger sufficient T cell responses in a therapeutic tumor treatment, nanovaccines offer unique properties to tackle that challenge. Here, we report the stepwise development of a nanocapsule for vaccination approaches, comprising a shell consisting of antigen and loaded with a superadditive adjuvant combination. In a first initial step, we identified the combination of resiquimod (R848) and mur…

CD4-Positive T-Lymphocytes0301 basic medicineCell SurvivalOvalbuminT-Lymphocytesmedicine.medical_treatmentT cellPharmaceutical ScienceMice Transgenic02 engineering and technologyCD8-Positive T-LymphocytesCancer VaccinesCell Line03 medical and health scienceschemistry.chemical_compoundNanocapsulesAntigenmedicineAnimalsHumansAntigensCytotoxicityAdjuvants PharmaceuticCell ProliferationChemistryImidazolesDextransDendritic CellsDendritic cell021001 nanoscience & nanotechnologyCell biologyMice Inbred C57BL030104 developmental biologymedicine.anatomical_structureCytokinesSpermineResiquimod0210 nano-technologyAcetylmuramyl-Alanyl-IsoglutamineAdjuvantMuramyl dipeptideCD8Journal of Controlled Release
researchProduct

LFA-1 activity state on dendritic cells regulates contact duration with T cells and promotes T-cell priming.

2010

AbstractA key event in the successful induction of adaptive immune responses is the antigen-specific activation of T cells by dendritic cells (DCs). Although LFA-1 (lymphocyte function–associated antigen 1) on T cells is considered to be important for antigen-specific T-cell activation, the role for LFA-1 on DCs remains elusive. Using 2 different approaches to activate LFA-1 on DCs, either by deletion of the αL-integrin cytoplasmic GFFKR sequence or by silencing cytohesin-1–interacting protein, we now provide evidence that DCs are able to make use of active LFA-1 and can thereby control the contact duration with naive T cells. Enhanced duration of DC/T-cell interaction correlates inversely …

Time FactorsT cellT-LymphocytesImmunologyReceptors Antigen T-CellPriming (immunology)chemical and pharmacologic phenomenaMice TransgenicCell CommunicationBiologyLymphocyte ActivationBiochemistryMiceImmune systemAntigenmedicineCell AdhesionAnimalsHypersensitivity DelayedLymphocyte function-associated antigen 1Antigen-presenting cellCells CulturedCell ProliferationMice KnockoutReverse Transcriptase Polymerase Chain ReactionMembrane Proteinshemic and immune systemsCell BiologyHematologyT lymphocyteDendritic cellDendritic CellsTh1 CellsFlow CytometryIntercellular Adhesion Molecule-1Lymphocyte Function-Associated Antigen-1Cell biologyMice Inbred C57BLmedicine.anatomical_structureImmunologyInterleukin-2RNA InterferenceCarrier ProteinsBlood
researchProduct

Abstract CT034: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy

2017

Abstract Therapeutic vaccination with tumor antigen-encoding RNAs by local administration is currently being successfully employed in various clinical trials. Advancing from local to more efficient systemic targeting of antigen-presenting cells (APCs), we have developed pioneering RNA-lipoplex (RNA(LIP)) immunotherapeutics for intravenous application based on the employment of well-known lipid carriers without the need for functionalization of particles with molecular ligands. The novel RNA(LIP) formulation has been engineered to preserve RNA integrity after intravenous injection and physicochemically optimized for efficient uptake and expression of the encoded antigen by APCs in various ly…

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtybusiness.industryImmunogenicitymedicine.medical_treatmentCancer02 engineering and technologyImmunotherapy021001 nanoscience & nanotechnologymedicine.diseaseClinical trialVaccination03 medical and health sciences030104 developmental biologyOncologyTolerabilityAntigenInternal medicinemedicineCancer vaccine0210 nano-technologybusinessCancer Research
researchProduct

Differentiation of frontal fibrosing alopecia and Lichen planopilaris on trichoscopy: A comprehensive review.

2021

Trichoscopy in dermatology has opened up the new concept in overcoming the optical challenge faced clinically. It reveals the diagnostic details to the depth of superficial dermis, and thereby increasing the clinician's diagnostic accuracy and the level of confidence. The importance of trichoscopy in cicatricial alopecia is very evident in the current scenario for its precise diagnosis. The clinical picture in delineating lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) from each other and also from other close mimickers such as androgenetic alopecia, alopecia areata, female patterned hair loss, and other cicatricial alopecia is bewildered due to its varied presentation and co…

medicine.medical_specialtyintegumentary systemAlopecia Areatabusiness.industryFrontal fibrosing alopecia610 MedizinLichen PlanusDiagnostic accuracyAlopeciaDermatologyAlopecia areatamedicine.diseaseLichen planopilarisDermatologyTrichoscopybody regionsstomatognathic diseasesCicatrixHair loss610 Medical sciencesmedicineHumansFemaleskin and connective tissue diseasesbusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity

2008

Despite as yet limited clinical effectiveness, dendritic cell (DC)-based immunotherapy remains a promising approach for the treatment of cancer, but requires further improvement in its immunostimulatory effectiveness. Potent anti-tumor immunity often depends on the induction of type 1 (T(H)1) immune responses. Therefore, we combined different DC maturation stimuli that are known to induce T(H)1 immunity [anti-CD40, interleukin (IL)-12, IL-18], with the aim to trigger a T(H)1 driven anti-tumor CTL response. When compared with untreated DC or DC treated with anti-CD40 alone, DC matured with anti-CD40 plus IL-12 and IL-18 expressed significantly more IFN-gamma and IL-12, induced enhanced CD8(+…

medicine.medical_treatmentAntineoplastic AgentsDermatologyCD8-Positive T-LymphocytesModels BiologicalBiochemistryMiceImmune systemAntigens NeoplasmmedicineAnimalsCD40 AntigensAntigen-presenting cellMolecular BiologyMice Inbred BALB Cbusiness.industryInterleukin-18InterleukinDendritic CellsImmunotherapyDendritic cellTh1 CellsInterleukin-12Tumor antigenMice Inbred C57BLImmune SystemImmunologyInterleukin 12ImmunotherapybusinessCD8Experimental Dermatology
researchProduct

Antigen dose-dependent suppression of murine IgE responses is mediated by CD4−CD8− double-negative T cells

2010

Background The IgE response against protein antigens is profoundly influenced by the dose used for sensitization. Objective The aim of the study was to identify immune cells that are involved in antigen dose-dependent regulation of IgE formation. Methods Wild-type mice as well as T helper (Th)1-deficient IL-12p40(-/-) and IFN-gamma(-/-) mice were immunized by repeated intraperitoneal injection of either low doses (K01 mice) or high doses (K100 mice) of keyhole limpet haemocyanin adsorbed to aluminium hydroxide. Splenocytes of immunized mice were restimulated in vitro and antigen-dependent T cell proliferation and cytokine production were measured. The frequency of regulatory T cell subsets …

biologyRegulatory T cellT cellImmunologyPriming (immunology)T lymphocyteImmunoglobulin Emedicine.anatomical_structureAntigenImmunologybiology.proteinmedicineImmunology and AllergyCytotoxic T cellCD8Clinical & Experimental Allergy
researchProduct

Differential gene expression analysis identifies murine Cacnb3 as strongly upregulated in distinct dendritic cell populations upon stimulation

2011

Langerhans cells (LCs) represent the dendritic cell (DC) population in the epidermis. Among the set of genes induced in primary mouse LCs in response to stimulation, both isoforms of the voltage-dependent Ca²(+) channel (VDCC) regulatory subunit Cacnb3 as well as the DC maturation marker Fscn1 were upregulated most strongly. Comparable results were obtained for a recently described myeloid DC line (SP37A3). Other antigen presenting cell populations, namely, bone marrow-derived DCs, macrophages and primary B cells, showed no stimulation-associated upregulation of Cacnb3 expression. Pharmacological inhibition of Ca²(+) channel activity during the stimulation of SP37A3 cells enhanced their T c…

Gene isoformT cellMolecular Sequence DataBiologyTransfectionMiceDownregulation and upregulationGeneticsmedicineAnimalsProtein IsoformsRNA MessengerAntigen-presenting cellRegulation of gene expressionMice Inbred BALB CBase SequenceCell DifferentiationDendritic CellsGeneral MedicineTransfectionDendritic cellMolecular biologyUp-RegulationCell biologymedicine.anatomical_structureGene Expression RegulationCell cultureLangerhans CellsCalcium ChannelsGene
researchProduct

A Brief Synopsis on Scalp Melanoma

2020

Melanoma constitutes one of the most sinister and troublesome malignancies encountered by humanity. Generally, the diagnosis of advanced melanoma connotes a grave prognosis, prompting a sense of looming threat of death, however, the early-stage detected disease responds well to robust treatment resulting in reasonable survivorship. Scalp melanomas are even more troublesome, because they typically exhibit more aggressive biologic behavior and are often diagnosed at a late stage. This review tries to comprehensively highlight the various diagnostic, therapeutic, and outcome aspects of scalp melanomas. The literature research includes peer-reviewed articles (clinical trials or scientific revie…

Melanomasmedicine.medical_specialtySkin NeoplasmsMEDLINEDermatologyEnglish languageDiseaseBreslow thickness; head and neck melanomas; melanomas; scalp melanomas; skin malignancies; Humans; Prognosis; Scalp; Head and Neck Neoplasms; Melanoma; Skin NeoplasmsBreslow thickne030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansMelanomaScalp melanomaAdvanced melanomaScalpHead and neck melanomabusiness.industryMelanomaLate stageHead and neck melanomasGeneral MedicinePrognosismedicine.diseaseDermatologyBreslow thickness; Head and neck melanomas; Melanomas; Scalp melanomas; Skin malignanciesClinical trialmedicine.anatomical_structureScalp melanomasHead and Neck NeoplasmsSkin malignancies030220 oncology & carcinogenesisScalpbusinessBreslow thickness
researchProduct

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 1: Epidemiology, Genetics and Diagnosis

2018

Basal cell carcinoma is the most common malignant tumor among fair-skinned individuals, and its incidence has been rising steadily in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 1 highlights new developments in genetics in particular as well as aspects regarding epidemiology, diagnosis, and histology.

Geneticsmedicine.medical_specialtyMolecular epidemiologybusiness.industryIncidence (epidemiology)MEDLINEDermatologyDiseasemedicine.disease3. Good health030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineEpidemiologymedicineCarcinomaBasal cell carcinomaProfessional associationbusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

A novel plasmid DNA electroporation method allows transfection of murine DC.

2007

Under steady state conditions dendritic cells (DC) exert tolerogenic function, but acquire potent immunogenic function due to strong upregulation of costimulatory molecules and proinflammatory cytokines. In numerous studies the potential of modified DC to induce tolerance or immune reactions towards a distinct antigen has been demonstrated. However, DC are refractory to transfection with plasmid DNA by non-viral methods. In this study we have tested the suitability of a newly developed electroporation device to transfect immature murine bone-marrow derived DC (BM-DC). Transfected BM-DC expressed reporter molecules at considerable extent which renders this method suitable to perform all kind…

CD4-Positive T-LymphocytesvirusesTransgeneT cellImmunologyGenetic VectorsGene ExpressionMice TransgenicBiologyTransfectionProinflammatory cytokineMyelin oligodendrocyte glycoproteinMicemedicineImmunology and AllergyAnimalsTransgenesCells CulturedCell ProliferationMice Inbred BALB CExpression vectorElectroporationTransfectionDendritic cellDendritic CellsMolecular biologyInterleukin-10Mice Inbred C57BLMyelin-Associated Glycoproteinmedicine.anatomical_structureElectroporationbiology.proteinFemaleMyelin-Oligodendrocyte GlycoproteinMyelin ProteinsPlasmidsJournal of immunological methods
researchProduct

Effect of estrogen in malignant melanoma

2021

Background Melanoma is associated with poor prognosis in its advanced stages. Potential influence of estrogen and its metabolites on melanoma growth has been suggested. Aims The objective of this review was to provide an overview on the evidence related to estrogen in malignant melanoma. Materials and methods Literature search using PubMed, Google Scholar and relevant cross-references of the retrieved articles was performed to review relevant published articles related to estrogen and its effects in malignant melanoma. Results Effect of estrogen signaling on a tissue largely depends on the relative expression of estrogen receptors (ER) α and β. Gender differences in melanoma may be explaine…

Poor prognosisSkin Neoplasmsbusiness.industrymedicine.drug_classMelanomaEstrogen Receptor alpha610 MedizinEstrogen receptorStimulationEstrogensDermatologymedicine.diseaseMetastasisEstrogen610 Medical sciencesCancer researchEstrogen signalingMedicineEstrogen Receptor betaHumansbusinessReceptorMelanoma
researchProduct

Two brothers with confluent and reticulated papillomatosis.

2016

030207 dermatology & venereal diseases03 medical and health sciencesPathologymedicine.medical_specialty0302 clinical medicinebusiness.industry030220 oncology & carcinogenesisConfluent and reticulated papillomatosismedicineDermatologymedicine.diseasebusinessJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
researchProduct

Long-lasting tumor response on short-time administration of vemurafenib—A case report

2014

Vemurafenib has been approved since 2011 in the United States for the treatment of advanced BRAF V600–mutated melanoma as first-line therapy. Although it significantly prolongs overall and progression-free survival, most patients relapse within 6 to 8 months owing to acquisition of drug resistance. New findings suggest that discontinuous dose administration of vemurafenib might prolong response to vemurafenib, but it is unclear whether modified cell signalling or other mechanisms, such as immune-mediated effects, are responsible for this effect.

Long lastingOncologymedicine.medical_specialtybusiness.industryMelanomashort-time treatmentCase ReportDermatologyDrug resistancePharmacologyTumor responsemedicine.diseaseInternal medicinemelanomamedicinevemurafenibbusinessVemurafenibmedicine.drugJAAD Case Reports
researchProduct

Acquired symmetric asymptomatic lesions at the inner corners of the eyes

2017

medicine.medical_specialtyText miningbusiness.industrymedicineDermatologyRadiologymedicine.symptombusinessAsymptomaticJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naïve T cells, and favors expansion of regulatory T ce…

2007

AbstractRetroviruses have developed immunmodulatory mechanisms to avoid being attacked by the immune system. The mechanisms of this retrovirus-associated immune suppression are far from clarified. Dendritic cells (DCs) have been attributed a decisive role in these pathogenic processes. We have used the Friend retrovirus (FV) mouse model in order to acquire further knowledge about the role of infection of DCs in virus-induced immunosuppression. About 20% of the myeloid DCs that were generated from the bone marrow of FV-infected mice carried FV proteins. The infection was productive, and infected DCs transmitted the virus in cell culture and in vivo. FV infection of DCs led to a defect in DC …

MyeloidImmunologyPopulationMedizinBone Marrow CellsMice Transgenicchemical and pharmacologic phenomenaCell CommunicationBiologyLymphocyte ActivationT-Lymphocytes RegulatoryBiochemistryMiceImmune systemAntigenImmune TolerancemedicineAnimalsCytotoxic T cellMyeloid CellseducationCell ProliferationAntigen PresentationMice Inbred BALB Ceducation.field_of_studyFollicular dendritic cellsModels ImmunologicalFOXP3hemic and immune systemsDendritic CellsCell BiologyHematologyFriend murine leukemia virusCell biologymedicine.anatomical_structureImmunologyBone marrowRetroviridae InfectionsBlood
researchProduct

Enhanced production of CCL18 by tolerogenic dendritic cells is associated with inhibition of allergic airway reactivity

2012

Background IL-10–treated dendritic cells (DCs) have been shown to inhibit T-cell responses through induction of anergy and regulatory T cells in various model systems, including allergic inflammation, but the factors being involved in this inhibition are still unclear. Objective This study set out to analyze such factors produced or induced by IL-10–treated DCs by using gene expression profiling and to explore their function. Methods CD4 + T cells from allergic donors were stimulated with autologous monocyte-derived allergen-pulsed mature DCs or IL-10–treated DCs. After 24 hours, the transcriptional profile was analyzed by using Affymetrix technology. Results were validated by using quantit…

CD4-Positive T-LymphocytesChemokinemedicine.medical_treatmentImmunologyT-Lymphocytes RegulatoryAllergic inflammationMiceMice Inbred NODImmune ToleranceRespiratory HypersensitivitymedicineAnimalsHumansImmunology and AllergyCCL17dendritic cellsCells CulturedT(H)1/T(H)2 cellsMice KnockoutbiologyCCL18FOXP3regulationDendritic cellMicroarray AnalysisallergyCoculture TechniquesInterleukin-10Disease Models Animalhumanized miceCytokineChemokines CCImmunologyHumanized mousebiology.proteinChemokinesTranscriptomeJournal of Allergy and Clinical Immunology
researchProduct

Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review.

2020

Psoriasis, a T-cell mediated chronic dermatosis, has a complex etiopathogenesis. There has been extensive research into the aberrant immune response, which leads to the formation of clinical lesions, and the need for developing better and safer drugs has been unrelenting. The past two decades of research has opened up new areas of the immune pathway that can be targeted in order to control the disease. Therefore, we have seen the emergence of biologics which either target T-cell receptors or inhibit Tumor Necrosis Factor-alpha (TNF-α) or inhibit interleukins (IL) like IL-12, IL-17, IL-17 receptor, and more recently IL-23. Drugs specifically targeting the p19 subunit of IL-23 have shown prom…

Plaque psoriasisCell signalingbusiness.industryInterleukinDermatologyGeneral MedicineDiseasemedicine.diseaseAntibodies Monoclonal HumanizedInterleukin-23030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineImmune system030220 oncology & carcinogenesisPsoriasisImmunologymedicineHumansPsoriasisTh17 CellsTumor necrosis factor alphaReceptorbusinessDermatologic therapyREFERENCES
researchProduct

The RNA binding protein tristetraprolin influences the activation state of murine dendritic cells

2010

Abstract Dendritic cells (DCs) serve to maintain peripheral tolerance under steady state conditions. Upon triggering by activation signals they initiate strong immune responses. The activation of DCs is accompanied by a rapid upregulation of proinflammatory cytokines, which were shown in other cell types to be regulated by mechanisms at the transcriptional and posttranscriptional level. Tristetraprolin (TTP), an important RNA binding protein, is involved in the regulation of mRNA stability of such cytokines. In this study we analyzed the significance of TTP for mouse DCs, which were derived from TTP −/− and WT bone marrow progenitor cells (BM-DCs). Unstimulated BM-DCs of TTP −/− mice expres…

LipopolysaccharidesRNA Stabilitymedicine.medical_treatmentT cellInterleukin-1betaImmunologychemical and pharmacologic phenomenaBiologyProinflammatory cytokineMiceTristetraprolinDownregulation and upregulationhemic and lymphatic diseasesmedicineAnimalsRNA MessengerCD40 AntigensMolecular BiologyMice KnockoutCD86Mice Inbred BALB CCD40Histocompatibility Antigens Class IIRNA-Binding ProteinsPeripheral toleranceDual Specificity Phosphatase 1hemic and immune systemsDendritic Cellsrespiratory systemUp-RegulationCell biologyCytokinemedicine.anatomical_structureImmunologybiology.proteinFemaleB7-2 AntigenProto-Oncogene Proteins c-fosCD80Molecular Immunology
researchProduct

Hämatom, Serom oder solider Tumor – Fallstricke in der Sonografie

2019

Ultraschall in der Medizin - European Journal of Ultrasound
researchProduct

Screening for distress in routine oncological care-a survey in 520 melanoma patients.

2012

Introduction Despite the increasing incidence of melanoma little is known about patients' emotional distress associated with this disease. Supplemented by the problem list (PL), the distress thermometer (DT) is a recommended screening instrument to measure psychosocial distress in cancer patients. Our objective was to explore the acceptance and the feasibility of the DT and PL as a concise screening tool in an ambulatory setting for routine care and to elucidate determinants of distress in melanoma patients with regard to sociodemographic and clinical variables. Methods Consecutive melanoma outpatients were asked to complete the DT with the PL prior to their scheduled consultation. Demograp…

MaleMelanomasPediatricsSkin NeoplasmsNon-Clinical MedicineEpidemiologyEmotionsProblem listlcsh:MedicineDiseaseSocial and Behavioral SciencesQuality of lifeRisk FactorsSurveys and QuestionnairesOutpatientsMass ScreeningPsychologyYoung adultlcsh:ScienceMelanomaSkin TumorsAged 80 and overMultidisciplinaryIncidence (epidemiology)Malignant MelanomaMiddle AgedDistressClinical PsychologyMental HealthOncologyMedicineFemalePsychosocialResearch ArticleTest EvaluationAdultmedicine.medical_specialtyAdolescentSocial PsychologyPsychological StressMalignant Skin NeoplasmsDermatologyYoung AdultDiagnostic MedicinemedicineHumansPsychiatryMass screeningAgedBehaviorHealth Care Policybusiness.industrylcsh:RCancers and NeoplasmsSurvey MethodsHealth Care SurveysQuality of Lifelcsh:QbusinessStress PsychologicalPLoS ONE
researchProduct

Brief S2k guidelines - Merkel cell carcinoma

2013

Jurgen C. Becker, Chalid Assaf, Dirk Vordermark, Sven N. Reske, Jorg Hense, Therese Dettenborn, Oliver Seitz, Stephan Grabbe (1) Division of General Dermatology, Graz University Hospital, Austria (2) Department of Dermatology, HELIOS Klinikum, Krefeld, Germany (3) Department of Radiotherapy, University Hospital Halle (Saale), Germany (4) Department of Nuclear Medicine, University Hospital Ulm, Germany (5) Department of Internal Medicine, University Hospital Essen, Germany (6) Department of Plastic Surgery, Hornheide Clinic, Munster, Germany (7) Department of Oral and Maxillofacial Surgery, University of Frankfurt Hospital, Germany (8) Department of Dermatology, Mainz University Hospital, Ge…

medicine.medical_specialtybusiness.industryMerkel cell carcinomaGeneral surgeryOral and maxillofacial surgeryMedicineDermatologyUniversity hospitalbusinessmedicine.diseaseJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Abstract CT202: IVAC MUTANOME: Individualized vaccines for the treatment of cancer

2015

Abstract Cancer arises from the accumulation of genomic alterations and epigenetic changes that constitute a hallmark of cancer. Owing to the molecular heterogeneity in cancer, only a minor fraction of patients profit from approved therapies. Available targeted therapies can only address alterations common to a particular type of cancer and induce transient effects due to the generation of resistant sub-clones. In contrast, the IVAC MUTANOME project aims to immunologically target multiple cancer mutations uniquely expressed in a given patient's tumor. The IVAC MUTANOME approach should be applicable to the majority of patients irrespective of the tumor entity and offers the potential to expl…

PrioritizationGerontologyOncologyCancer Researchmedicine.medical_specialtybusiness.industryMelanomaCancermedicine.diseaseMolecular heterogeneityPhase i studyClinical trialOncologyTolerabilityInternal medicinemedicinebusinessExomeCancer Research
researchProduct

Mutated cylindromatosis gene affects the functional state of dendritic cells

2010

Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating enzyme, which interacts with members of the NF-κB signaling pathway and attenuates NF-κB and JNK signaling. Here, we report that DC derived from transgenic mice, which solely express a naturally occurring CYLD isoform (CYLD(ex7/8)), display a higher content of nuclear RelB and express elevated levels of NF-κB family members as well as of known NF-κB-target genes comprising costimulatory molecules and pro-inflammatory cytokines, as compared with WT DC. Accordingly, unstimulated CYLD(ex7/8) DC exhibited a significantly higher primary allogenic T-cell stimulatory capacity than WT DC and exerted no tolerogenic activity. Tr…

Genetically modified mouseTransgeneBlotting WesternImmunologyMice TransgenicBiologyDexamethasoneDeubiquitinating enzymeSmall hairpin RNAMiceImmune ToleranceAnimalsImmunology and AllergyGlucocorticoidsMice KnockoutReverse Transcriptase Polymerase Chain ReactionTumor Suppressor ProteinsRELBTranscription Factor RelBNF-kappa BPeripheral toleranceCell DifferentiationDendritic CellsFlow CytometrySpecific Pathogen-Free OrganismsCell biologyIsoenzymesTranscription Factor AP-1MutationKnockout mouseImmunologybiology.proteinRNAFemaleSignal transductionSignal TransductionEuropean Journal of Immunology
researchProduct

A trifunctional dextran-based nanovaccine targets and activates murine dendritic cells, and induces potent cellular and humoral immune responses in v…

2013

Dendritic cells (DCs) constitute an attractive target for specific delivery of nanovaccines for immunotherapeutic applications. Here we tested nano-sized dextran (DEX) particles to serve as a DC-addressing nanocarrier platform. Non-functionalized DEX particles had no immunomodulatory effect on bone marrow (BM)-derived murine DCs in vitro. However, when adsorbed with ovalbumine (OVA), DEX particles were efficiently engulfed by BM-DCs in a mannose receptor-dependent manner. A DEX-based nanovaccine containing OVA and lipopolysaccharide (LPS) as a DC stimulus induced strong OVA peptide-specific CD4(+) and CD8(+) T cell proliferation both in vitro and upon systemic application in mice, as well a…

CD4-Positive T-LymphocytesLipopolysaccharidesOvalbumin610 Medizinlcsh:MedicineBone Marrow CellsReceptors Cell SurfaceCD8-Positive T-LymphocytesMiceTh2 Cells610 Medical sciencesAnimalsLectins C-Typelcsh:ScienceCell ProliferationImmunity CellularVaccineslcsh:RDextransDendritic CellsImmunity HumoralMannose-Binding LectinsNanoparticleslcsh:QAdsorptionMannose ReceptorResearch ArticlePLoS ONE
researchProduct

Prurigo nodularis as index symptom of (non-Hodgkin) lymphoma: ultrasound as a helpful diagnostic tool in dermatological disorders of unknown origin

2014

medicine.medical_specialtybusiness.industryLymphoma Non-HodgkinUltrasoundDermatologymedicine.diseaseDermatologyHumansMedicineHodgkin lymphomaFemalePrurigoDermatological disordersbusinessPrurigo nodularisAgedUltrasonographyInternational Journal of Dermatology
researchProduct

Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synerg…

2010

Abstract Synergistic activation of dendritic cells by combinations of TLR ligands requires both MyD88- and TRIF-dependent signaling. Recently, it has been shown that certain combinations of TLR ligands act in synergy to induce the release of IL-12 by DCs. In this study, we sought to define the critical parameters underlying TLR synergy. Our data show that TLR ligands act synergistically if MyD88- and TRIF-dependent ligands are combined. TLR4 uses both of these adaptor molecules, thus activation via TLR4 proved to be a synergistic event on its own. TLR synergy did not affect all aspects of DC activation but enhanced primarily the release of certain cytokines, particularly IL-12, whereas the …

LipopolysaccharidesT cellImmunologyBiologyLymphocyte ActivationInterferon-gammaMicemedicineImmunology and AllergyAnimalsCD40 AntigensAutocrine signallingMice Inbred BALB CToll-Like ReceptorsSignal transducing adaptor proteinCell PolarityCell BiologyDendritic CellsInterleukin-12Cell biologyMice Inbred C57BLAdaptor Proteins Vesicular Transportmedicine.anatomical_structurePoly I-CTRIFImmunologyMyeloid Differentiation Factor 88TLR4Interleukin 12Myeloid Differentiation Factor 88Signal transductionSignal TransductionJournal of leukocyte biology
researchProduct

Pembrolizumab-induzierter Lichen planus pemphigoides bei einem Patienten mit metastasiertem Melanom

2017

030207 dermatology & venereal diseases03 medical and health sciencesmedicine.medical_specialty0302 clinical medicinebusiness.industryMedicineDermatologybusinessDermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Increased risk of angiosarcoma secondary to cancer radiotherapy: Case series and review of the treatment options.

2020

Angiosarcomas (ASs) are aggressive tumors of vascular endothelial origin, occurring sporadically or in association with prior radiotherapy or chronic lymphedema. With only 1-5% of all sarcomas, the incidence seems low, but for the affected patient due to the extremely poor prognosis and the limited treatment options, the fate is often inevitable. Radiotherapy, chemotherapy, or "target therapy" have been used in the management of AS, but represent individual case decisions without lasting evidence. Over the past few years, breast-conserving surgery followed by radiation therapy, known as breast-conserving therapy (BCT), is being employed as a standard treatment for early-stage breast cancer,…

medicine.medical_specialtymedicine.medical_treatmentHemangiosarcomaBreast NeoplasmsDermatologyMastectomy Segmental030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineBreast cancermedicineHumansAngiosarcomaChemotherapybusiness.industryStandard treatmentIncidence (epidemiology)IncidenceTreatment optionsGeneral Medicinemedicine.diseasePrognosisRadiation therapy030220 oncology & carcinogenesisCancer RadiotherapyRadiologybusinessDermatologic therapyREFERENCES
researchProduct

Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immun…

2020

Simple Summary The introduction of immune-checkpoint inhibitors improved the therapeutic landscape for patients with advanced malignant melanoma. However, many patients, including patients with melanoma brain metastases, do not derive benefit from immune-checkpoint blockade. Hence, biomarkers are needed to identify potential mechanisms of resistance and optimize patient selection. This study aimed to explore the role of hypoxia-mediated immunosuppression within the tumor microenvironment of patients with metastatic melanoma using multiplex immunofluorescence. We analyzed the prognostic relevance of the hypoxia surrogate marker GLUT-1, the adenosine-synthesizing ectoenzymes CD73/CD39, and th…

0301 basic medicineCancer Researchmultiplex immunohistochemistrymedicine.medical_treatmentimmune checkpoint inhibitorIpilimumablcsh:RC254-282Articlespatial statistics03 medical and health sciences0302 clinical medicineImmune systemmedicineCytotoxic T celltumor microenvironmentipilimumabradiotherapyTumor microenvironmentimmunosuppressionbusiness.industryhypoxiaMelanomaImmunosuppressionmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCTL*030104 developmental biologyOncologyadenosine030220 oncology & carcinogenesisCancer researchbusinessCD8medicine.drugCancers
researchProduct

Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers

2021

AbstractThe major challenge of nanocarrier-based anti-cancer vaccination approaches is the targeted delivery of antigens and immunostimulatory agents to cells of interest, such as specific subtypes of dendritic cells (DCs), in order to induce robust antigen-specific anti-tumor responses. An undirected cell and body distribution of nanocarriers can lead to unwanted delivery to other immune cell types like macrophages reducing the vaccine efficacy. An often-used approach to overcome this issue is the surface functionalization of nanocarriers with targeting moieties, such as antibodies, mediating cell type-specific interaction. Numerous studies could successfully prove the targeting efficiency…

biologyChemistrymedicine.medical_treatmentCellFc receptorDendritic cellCell biologymedicine.anatomical_structureImmune systemAntigenCancer immunotherapybiology.proteinmedicineNanocarriersAntibody
researchProduct

Systemische Immunsuppression in Zeiten von COVID‐19: Müssen wir umdenken?

2020

Zusammenfassung Die aktuelle SARS‐CoV‐2 Pandemie gefährdet vor allem ältere Menschen mit kardiopulmonalen und metabolischen Vorerkrankungen. In aktueller Diskussion ist jedoch auch, ob Patienten unter immunsuppressiver Therapie ebenfalls ein höheres Risiko haben, im Fall einer COVID‐19‐Erkrankung einen schweren Krankheitsverlauf zu erleiden. Grundsätzlich gibt es derzeit jedoch keine Datenlage für eine generelle Reduktion oder Pausierung einer Immunsuppression bei Patienten mit Autoimmunerkrankungen in Zeiten der SARS‐CoV‐2‐Pandemie. Da es jedoch derzeit weder eine wirksame Therapie, noch einen entsprechenden Impfschutz gibt, sollten wir uns gezielt mit der Problematik chronisch‐immunsuppri…

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineDermatologyReviewbusinessVirologyJournal Der Deutschen Dermatologischen Gesellschaft
researchProduct

Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells.

2010

Advanced glycation endproducts (AGEs) of food proteins resulting from the Maillard reaction after cooking or heating may have particular importance in food allergy. The underlying immunological mechanisms are only poorly understood. The aim of the study was to examine the effects of AGE derived from the model food allergen ovalbumin (AGE-OVA) on dendritic cells (DCs), their immunostimulatory capacity and the T-cell response compared with regular OVA. For this purpose, human immature DCs were exposed to fluorescein isothiocyanate (FITC)-labelled AGE-OVA and FITC-labelled regular OVA and uptake was analysed by flow cytometry and fluorescence microscopy. Furthermore, autologous CD4(+) T-cell p…

CD4-Positive T-LymphocytesGlycation End Products AdvancedOvalbuminmedicine.medical_treatmentImmunologyReceptor for Advanced Glycation End ProductsLymphocyte ActivationAntibodiesRAGE (receptor)chemistry.chemical_compoundTh2 CellsAntigenGlycationmedicineImmunology and AllergyHumansScavenger receptorPhosphorylationReceptors ImmunologicFluorescein isothiocyanateCell ProliferationAntigen PresentationbiologyInterleukin-6Transcription Factor RelADendritic CellsOriginal Articlesrespiratory systemAllergensTh1 CellsEndocytosisCell biologyOvalbuminCytokinechemistryImmunologybiology.proteinCytokinesMannose receptorFood HypersensitivityImmunology
researchProduct

Therapeutic options in vitiligo with special emphasis on immunomodulators: A comprehensive update with review of literature

2020

Vitiligo is a relatively common disorder characterized by areas of depigmented skin. It may be associated with social stigma and adversely affects the quality of life. Although many treatment options are available, none is curable. The search continues for an effective therapeutic option. New targeted options include biologics and other immunomodulatory agents, with varying degrees of evidence. We have discussed briefly the therapeutic options with special emphasis on the newer immunomodulatory agents. We undertook a comprehensive English literature search across multiple databases such as PubMed, SCOPUS, EMBASE, MEDLINE, and Cochrane using keywords (alone and in combination) and MeSH items…

medicine.medical_specialtybusiness.industryVitiligoMEDLINETreatment optionsDermatologyGeneral MedicineVitiligomedicine.diseaselaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled triallaw030220 oncology & carcinogenesisQuality of LifemedicineHumansImmunologic FactorsProspective StudiesIntensive care medicinebusinessPUVA TherapyDermatologic Therapy
researchProduct

Update in minimally invasive periorbital rejuvenation with a focus on platelet-rich plasma: A narrative review.

2020

Background The periorbital region is among the first areas to be affected by the process of aging, which is influenced by genetic and constitutional factors. As the region plays an important role in overall facial appearance, rejuvenation of the area has immense cosmetic benefit and various treatment modalities have been used to achieve the same. Aims This article reviews commonly used non-surgical and minimally invasive modalities for periorbital rejuvenation. Methods The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) and reference lists of respective articles.…

medicine.medical_specialtyMEDLINEDermatologyCosmetic TechniquesPeriorbital rejuvenation030207 dermatology & venereal diseases03 medical and health sciencesBlood Transfusion Autologous0302 clinical medicineMedicineHumansRejuvenationRejuvenationModalitiesModality (human–computer interaction)business.industryPlatelet-Rich PlasmaDermatologySkin AgingClinical trialTreatment Outcome030220 oncology & carcinogenesisPlatelet-rich plasmaFaceNarrative reviewbusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

Safety of the current drug treatments for vitiligo

2020

Introduction: Vitiligo is an acquired depigmenting skin disorder adversely affecting the patient's quality of life. Despite the presence of several treatment modalities, ranging from medical to physical to surgical options, none is curative. Each modality has its own drawbacks and side effects. Thus, the treatment modality needs to be tailored for each individual patient taking into consideration the disease characteristics and also its efficacy and safety to obtain a favorable risk-benefit ratio.Areas covered: This review highlights the different treatment modalities utilized in vitiligo up until 4 November 2019 along with their adverse effects and contraindications, if any.Expert opinion:…

Drugmedicine.medical_specialtymedia_common.quotation_subjectVitiligoVitiligo030204 cardiovascular system & hematologyAdministration Cutaneous03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Adrenal Cortex HormonesmedicineHumansEffective treatmentPharmacology (medical)Intensive care medicineAdverse effectmedia_commonBiological ProductsModality (human–computer interaction)business.industryGeneral Medicinemedicine.diseaseTreatment modality030220 oncology & carcinogenesisQuality of LifeDisease characteristicsDermatologic AgentsbusinessExpert Opinion on Drug Safety
researchProduct

Protein corona–mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses

2018

Background Nanoparticle (NP)–based vaccines are attractive immunotherapy tools because of their capability to codeliver antigen and adjuvant to antigen-presenting cells. Their cellular distribution and serum protein interaction ("protein corona") after systemic administration and their effect on the functional properties of NPs is poorly understood. Objectives We analyzed the relevance of the protein corona on cell type–selective uptake of dextran-coated NPs and determined the outcome of vaccination with NPs that codeliver antigen and adjuvant in disease models of allergy. Methods The role of protein corona constituents for cellular binding/uptake of dextran-coated ferrous nanoparticles (DE…

0301 basic medicineendocrine systemOvalbuminCpG OligodeoxynucleotideT-Lymphocytesmedicine.medical_treatmentImmunologyMice Transgenic02 engineering and technologyComplement factor IComplement receptor03 medical and health sciencesImmune systemAntigenLectinsHypersensitivitymedicineAnimalsImmunology and AllergyFerrous CompoundsAntigensAnaphylaxisB-LymphocytesDrug CarriersMice Inbred BALB CVaccinesChemistryDextransImmunotherapyrespiratory system021001 nanoscience & nanotechnologyComplement systemMice Inbred C57BL030104 developmental biologyOligodeoxyribonucleotidesImmunologyNanoparticlesFemaleProtein Corona0210 nano-technologyAdjuvantJournal of Allergy and Clinical Immunology
researchProduct

Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials

2021

BACKGROUND Ten-year survival rates in mycosis fungoides (MF) broadly varies, however, there is no standardized prognostic index available. This is presumably due to low prevalence, heterogeneity, and diagnostic challenges in MF. Recent studies have focused on identifying objective prognostic indices by using different parameters for survival determinants. The Cutaneous Lymphoma International Prognostic Index (CLIPI) and the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) represent prototypical studies that identify prognostic factors, seeking to improve management and outcomes in early-stage MF. Detecting these factors and stratifying MF patients according to their …

MaleOncologymedicine.medical_specialtySkin Neoplasms610 MedizinDermatologyDiseaseCutaneous lymphomaMycosis FungoidesInternational Prognostic IndexInternal medicine610 Medical sciencesmedicineHumansProspective StudiesStage (cooking)Neoplasm StagingMycosis fungoidesbusiness.industryLarge cellPrognosismedicine.diseaseLymphomaT-stageFemalebusiness
researchProduct

Grüntee‐Extrakt als erfolgreiche topische Behandlungsoption bei Kindern mit Condylomata acuminata im Perianalbereich

2021

Gynecologymedicine.medical_specialtybusiness.industrymedicineDermatologybusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – update 2018

2019

Merkel cell carcinoma (MCC, ICD-O M8247 / 3) is a rare malignant primary skin tumor with epithelial and neuroendocrine differentiation. The neoplastic cells share many morphological, immunohistochemical and ultrastructural characteristics with Merkel cells of the skin. The diagnosis of MCC is rarely made on clinical grounds. Histological and immunohistochemical studies are usually required to confirm the clinical suspicion. Given the frequent occurrence of occult lymph node metastasis, sentinel lymph node biopsy should be performed once distant metastasis has been ruled out by cross-sectional imaging. Primary tumors without evidence of organ metastases are treated with complete surgical exc…

medicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentSentinel lymph nodeMedizinAntineoplastic AgentsDermatologyNeuroendocrine differentiation030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineBiopsyCarcinomaHumansMedicineNeoadjuvant therapyAgedNeoplasm Stagingmedicine.diagnostic_testbusiness.industryMerkel cell carcinomaPrognosismedicine.diseaseNeoadjuvant TherapyCarcinoma Merkel CellRadiation therapymedicine.anatomical_structureLymphatic MetastasisImmunotherapyRadiologyNeoplasm Recurrence LocalCognition DisordersbusinessMerkel cell
researchProduct

Repression of Cyclic Adenosine Monophosphate Upregulation Disarms and Expands Human Regulatory T Cells

2011

Abstract The main molecular mechanism of human regulatory T cell (Treg)-mediated suppression has not been elucidated. We show in this study that cAMP represents a key regulator of human Treg function. Repression of cAMP production by inhibition of adenylate cyclase activity or augmentation of cAMP degradation through ectopic expression of a cAMP-degrading phosphodiesterase greatly reduces the suppressive activity of human Treg in vitro and in a humanized mouse model in vivo. Notably, cAMP repression additionally abrogates the anergic state of human Treg, accompanied by nuclear translocation of NFATc1 and induction of its short isoform NFATc1/αA. Treg expanded under cAMP repression, however,…

medicine.medical_specialtyRegulatory T cellImmunologychemical and pharmacologic phenomenaBiologyT-Lymphocytes RegulatoryMicechemistry.chemical_compoundInternal medicineCyclic AMPmedicineAnimalsHumansImmunology and AllergyCyclic adenosine monophosphatePsychological repressionCell ProliferationClonal AnergyNFATC Transcription FactorsClonal anergyPhosphodiesterasehemic and immune systemsUp-RegulationCell biologyEndocrinologymedicine.anatomical_structurechemistryHumanized mousecAMP-dependent pathwayCyclase activityThe Journal of Immunology
researchProduct

Green tea extract as a successful topical treatment option in children with perianal condylomata

2020

TeaTraditional medicineCondylomata AcuminataPlant Extractsbusiness.industryHumansMedicineTopical treatmentDermatologyGreen tea extractChildbusinessAntioxidantsJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Toll like receptor mediated immune stimulation can be visualized in vivo by [ 18 F]FDG-PET

2016

Abstract Introduction High uptake of [ 18 F]-2-fluorodeoxyglucose ([ 18 F]FDG) by inflammatory cells is a frequent cause of false positive results in [ 18 F]FDG-positron-emission tomography (PET) for cancer diagnostics. Similar to cancer cells, immune cells undergo significant increases in glucose utilization following activation, e.g., in infectious diseases or after vaccination during cancer therapy. The aim of this study was to quantify certain immune effects in vitro and in vivo by [ 18 F]FDG-PET after stimulation with TLR ligands and specific antibodies. Methods In vivo [ 18 F]FDG-PET/magnetic resonance imaging (MRI) and biodistribution was performed with C57BL/6 mice immunized with Cp…

0301 basic medicineCD86Cancer ResearchPathologymedicine.medical_specialtyB-cell receptorCD28Biology03 medical and health sciences030104 developmental biology0302 clinical medicinemedicine.anatomical_structureImmune systemIn vivo030220 oncology & carcinogenesisCancer cellmedicineCancer researchMolecular MedicineRadiology Nuclear Medicine and imagingLymph nodeCD80Nuclear Medicine and Biology
researchProduct

Non‐invasive diagnostic techniques in pigmentary skin disorders and skin cancer

2021

Background Diagnosis of pigmentary skin disorders, pre-cancerous and cancerous skin diseases is traditionally relied on visual assessment. The most widely applied invasive diagnostic technique is the skin biopsy. There have been significant technological advances in non-invasive diagnostic methods for skin disorders. Objective The objective of this article is to discuss different non-invasive diagnostic modalities, used in the diagnosis of pigmentary skin disorders and cutaneous cancers. Methods Comprehensive literature search was performed to screen articles related to non-invasive diagnostic techniques in pigmentary skin disorders and cutaneous cancers. Articles published in journals inde…

medicine.medical_specialtyMicroscopy ConfocalSkin Neoplasmsmedicine.diagnostic_testbusiness.industryNon invasiveMagnetic resonance imagingDermatologymedicine.diseaseSensitivity and SpecificityDermatologyDiagnostic modalitiesClinical trialOptical coherence tomographyBiopsySkin biopsymedicineHumansSkin cancerbusinessSkinUltrasonographyJournal of Cosmetic Dermatology
researchProduct

Granulomatous mycosis fungoides, a rare subtype of cutaneous T-cell lymphoma

2015

Granulomatous mycosis fungoides (GMF) is an unusual histologic subtype of cutaneous T-cell lymphoma.1 The diagnosis of GMF is usually established after observation of a granulomatous inflammatory reaction associated with a malignant lymphoid infiltrate. Epidermotropism, a clue to diagnosis in classical mycosis fungoides (MF) may be absent in about 47% of cases of GMF.2 In some instances, the granulomatous component may be intense and obscures the lymphomatous component of the infiltrate.1 There are no distinctive clinical patterns associated with GMF.1, 3

GMF granulomatous mycosis fungoidesPathologymedicine.medical_specialtyMycosis fungoidesgranulomatous mycosis fungoidesbusiness.industryCutaneous T-cell lymphomaT-Cell Receptor Gamma GeneCase ReportDermatologyGranulomatous mycosis fungoidesmedicine.diseaseDermatologyINF-α interferon alfaGranulomatous dermatitisTCR T-cell receptormedicineT-cell receptor gamma geneMF mycosis fungoidesGranulomatous DermatitisbusinessJAAD Case Reports
researchProduct

A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunothera…

2017

0301 basic medicineMessenger RNAbusiness.industrymedicine.medical_treatmentMelanomaHematologyFirst in humanImmunotherapymedicine.diseaseClinical trial03 medical and health sciences030104 developmental biology0302 clinical medicinePhase i iiOncologyAntigen030220 oncology & carcinogenesisCancer researchmedicinebusinessLipoplexAnnals of Oncology
researchProduct

The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery

2018

Nanocarriers (NC) are very promising tools for cancer immunotherapy. Whereas conventional vaccines are based on the administration of an antigen and an adjuvant in an independent fashion, nanovaccines can facilitate cell-specific co-delivery of antigen and adjuvant. Furthermore, nanovaccines can be decorated on their surface with molecules that facilitate target-specific antigen delivery to certain antigen-presenting cell types or tumor cells. However, the target cell-specific uptake of nanovaccines is highly dependent on the modifications of the nanocarrier itself. One of these is the formation of a protein corona around NC after in vivo administration, which may potently affect cell-speci…

0301 basic medicinelcsh:Immunologic diseases. AllergyMini Reviewmedicine.medical_treatmentImmunologyCellcell-specific targetingProtein Corona02 engineering and technology03 medical and health sciencesprotein coronaAntigenCancer immunotherapyIn vivoNeoplasmsmedicineHumansImmunology and AllergyReceptors ImmunologicnanocarriersChemistryImmunotherapy021001 nanoscience & nanotechnologyBody FluidsTreatment Outcome030104 developmental biologymedicine.anatomical_structureCancer researchNanoparticlesimmunotherapyNanocarriers0210 nano-technologylcsh:RC581-607Adjuvantcancer vaccinesProtein BindingFrontiers in Immunology
researchProduct

IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice

2007

Abstract UV radiation-induced immunosuppression contributes significantly to the development of UV-induced skin cancer by inhibiting protective immune responses. IL-10 has been shown to be a key mediator of UV-induced immunosuppression. To investigate the role of IL-10 during photocarcinogenesis, groups of IL-10+/+, IL-10+/−, and IL-10−/− mice were chronically irradiated with UV. IL-10+/+ and IL-10+/− mice developed skin cancer to similar extents, whereas IL-10−/− mice were protected against the induction of skin malignancies by UV. Because UV is able to induce regulatory T cells, which play a role in the suppression of protective immunity, UV-induced regulatory T cell function was analyzed…

Neoplasms Radiation-InducedSkin NeoplasmsUltraviolet RaysRegulatory T cellImmunologyMice NudeBiologymedicine.disease_causeT-Lymphocytes RegulatoryMiceImmune systemImmunityImmune TolerancemedicineAnimalsImmunology and AllergyIL-2 receptorMice KnockoutMolecular biologyInterleukin-10Mice Inbred C57BLInterleukin 10medicine.anatomical_structureImmunologyGranzyme ACytokinesCarcinogenesisCD8The Journal of Immunology
researchProduct

Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma

2017

Pemphigoidmedicine.medical_specialtyMetastatic melanomabusiness.industryFollow up studiesDermatologyPembrolizumabmedicine.diseaseDermatologyLichen planus pemphigoides030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMonoclonalmedicineNeoplasm stagingSkin pathologybusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

PeptoSomes for Vaccination: Combining Antigen and Adjuvant in Polypept(o)ide-Based Polymersomes.

2017

In this work, the first vaccine is reported based on a PeptoSome, which contains a model antigen (SIINFEKL) and adjuvant (CpG). PeptoSomes are polypept(o)ide-based polymersomes built of a block-copolymer with polysarcosine (PSar) as the hydrophilic block (X n = 111) and poly(benzyl-glutamic acid) (PGlu(OBn)) as the hydrophobic one (X n = 46). The polypept(o)ide is obtained with low dispersity index of 1.32 by controlled ring-opening polymerization. Vesicle formation by dual centrifugation technique allows for loading of vesicles up to 40 mol%. PeptoSomes are characterized by multiangle dynamic light scattering, static light scattering, and cryogenic transmission electron microscopy (cryoTEM…

Hydrodynamic radiusPolymers and Plasticsmedicine.medical_treatmentT-LymphocytesDispersityGene ExpressionBioengineeringchemical and pharmacologic phenomenaBone Marrow Cells02 engineering and technology010402 general chemistryLymphocyte Activation01 natural sciencesBiomaterialsPeptoidsDynamic light scatteringAntigenAdjuvants ImmunologicMaterials ChemistrymedicineHumansStatic light scatteringAntigensVaccinesChemistryVesicleVaccinationSarcosineDendritic Cells021001 nanoscience & nanotechnologyMolecular biologyCoculture Techniques0104 chemical sciencesOligodeoxyribonucleotidesPolymersomeB7-1 AntigenCytokinesB7-2 Antigen0210 nano-technologyPeptidesAdjuvantBiomarkersBiotechnologyMacromolecular bioscience
researchProduct

Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis.

2013

Allergic contact dermatitis (ACD) is one of the most common skin diseases, consisting of sensitization and elicitation phases. With the advancement of technology and the discovery of new types of immune cells, our knowledge of the immunological mechanisms of contact hypersensitivity (CHS) as a murine model of ACD has expanded significantly in the past decade. For example, by introducing regulatory T cells, CD4(+) T-helper 17 cells, and Langerin-positive dermal dendritic cells, the initiation and termination mechanism of CHS has been revealed. In addition, the role of mast cells in CHS, long a matter of debate, has become apparent by developing conditional mast cell-deficient mice. Moreover,…

Innate immune systemintegumentary systemDermal Dendritic CellsMechanism (biology)business.industryContact hypersensitivityCell BiologyDermatologymedicine.diseaseDermatitis ContactBiochemistryDisease Models AnimalMicemedicine.anatomical_structureImmune systemImmunologyDermatitis Allergic ContactmedicineAnimalsbusinessMolecular BiologyAllergic contact dermatitisContact dermatitisSensitizationSkinThe Journal of investigative dermatology
researchProduct

ADF Winter School-An exciting concept of the Arbeitsgemeinschaft Dermatologische Forschung to connect young scientists and clinician scientists in De…

2016

Medical educationmedicine.medical_specialtybusiness.industryDermatology clinicAlternative medicinemedicineDermatologybusinessMolecular BiologyBiochemistryExperimental Dermatology
researchProduct

Quality of life in melanoma patients during adjuvant treatment with pegylated interferon-α2b: patients’ and doctors’ views

2011

Treatment of malignant melanoma with IFN-α has been associated with significant side-effects. The aim of this retrospective monocentric non-randomized study was first to evaluate the impact on quality of life (QOL) in 30 melanoma patients treated with once weekly 2 μg/kg PEG-IFN-α2b for 18 months, and second to examine whether there is a difference in patients' and physicians' perception of QOL. Data on QOL were collected by means of the EORTC QLQ-C30 questionnaire completed by the patient before consultation at baseline and every three months during treatment. A second questionnaire was filled out independently by the physician, based on the consultation and patient file. All data were rou…

AdultMalemedicine.medical_specialtyAdolescentEvery Three Monthsmedicine.medical_treatmentOnce weeklyDermatologyInterferon alpha-2Antiviral AgentsPolyethylene GlycolsYoung AdultAmbulatory careQuality of lifePegylated interferonHumansMedicineIn patientMelanomaAgedRetrospective StudiesAged 80 and overbusiness.industryMelanomaInterferon-alphaMiddle Agedmedicine.diseaseRecombinant ProteinshumanitiesChemotherapy AdjuvantQuality of LifePhysical therapyFemalebusinessAdjuvantmedicine.drugEuropean Journal of Dermatology
researchProduct

Can SARS‐CoV‐2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review

2021

Abstract Introduction Although the COVID‐19 vaccination is deemed safe, exact incidence and nature if adverse effects, particularly dermatological ones, are still unknown. Objective To describe the demographic, clinical, morphological characteristics, outcomes, and timing of development of herpes zoster to the various COVID‐19 vaccines. And to identify on whether COVID‐19 vaccine has temporal relationship between development of herpes zoster (HZ). Methods We have performed a systemic review of articles from PubMed and Embase using MeSH and keywords like “Shingles,” “Herpes zoster,” “Varicella zoster,” “COVID‐19,” “Vaccine,” “SARS‐CoV‐2.” No filters including country of publication, language…

MalePediatricsmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)herpes zosterReview ArticleDermatologyMalignancyCovidVaricella zosterChickenpoxCOVID‐19vaccinemedicineHerpes Zoster VaccineHumansAdverse effectSARS-CoV-2business.industryIncidence (epidemiology)Metabolic disorderCOVID-19Middle Agedmedicine.diseaseVaccinationFemalebusinessShinglesJournal of Cosmetic Dermatology
researchProduct

Regulatory T Cells Prevent Neutrophilic Infiltration of Skin during Contact Hypersensitivity Reactions by Strengthening the Endothelial Barrier

2020

The healing phase of contact hypersensitivity reactions is critically dependent on regulatory T cells (Tregs), but even the early inflammatory phase, that is, 6-24 hours after induction of a contact hypersensitivity reaction, is susceptible to Treg-mediated suppression. To investigate the underlying mechanisms, we injected Tregs before the challenge and analyzed the skin-infiltrating cells as early as 6 hours later. Early on, we found mainly neutrophils in the challenged skin, but only a few T cells. This influx of neutrophils was blocked by the injection of Tregs, indicating that they were able to prevent the first wave of leukocytes, which are responsible for starting an immune reaction. …

0301 basic medicineNeutrophilsRegulatory T cellchemical and pharmacologic phenomenaCell CommunicationPicryl ChlorideDermatologyFilaminT-Lymphocytes RegulatoryBiochemistryProinflammatory cytokineMice03 medical and health sciences0302 clinical medicineDownregulation and upregulationNectinmedicineAnimalsHumansProtein kinase AMolecular BiologySkinChemistryChemotaxisCell BiologyCell biologyEndothelial stem cellDisease Models Animal030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisDermatitis Allergic ContactEndothelium VascularIntracellularJournal of Investigative Dermatology
researchProduct

Sentinel lymph node biopsy in malignant melanoma of the head and neck

2018

Abstract Background The aim of this retrospective study was to investigate sentinel lymph node biopsy in patients with head and neck melanoma. Materials and methods Patients who underwent SLNB between 2010 and 2016 were comprised. Epidemiological, radiological, and surgical data were collected and compared to histological findings. Patients who underwent primary complete lymph node dissection were excluded. Results 74 patients underwent SLNB during this period. The most common tumor localizations were the cheek (20.4%) and ears (20.4%). Overall, 256 sentinel lymph nodes (SLN) were detected and removed, most frequently in Robbins-levels IIA and IIB as well as in the surrounding of the paroti…

Malemedicine.medical_specialtySkin NeoplasmsSentinel lymph nodeMetastasis030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePredictive Value of TestsBiopsyHumansParotid GlandMedicineMelanomaLymph nodeAgedNeoplasm StagingRetrospective Studiesmedicine.diagnostic_testSentinel Lymph Node Biopsybusiness.industryMelanomaEarMiddle AgedPrognosismedicine.diseaseParotid glandCheekLymphatic systemmedicine.anatomical_structureOtorhinolaryngologyHead and Neck NeoplasmsLymphatic Metastasis030220 oncology & carcinogenesisLymph Node ExcisionFemaleSurgeryLymph NodesLymphRadiologyNeoplasm Recurrence LocalOral SurgerybusinessHeadNeckJournal of Cranio-Maxillofacial Surgery
researchProduct

Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis.

2011

Background Therapy of atopic dermatitis (AD) relies on immunosuppression and/or UV irradiation. Here, we assessed clinical efficacy and histopathological alterations induced by blue light-treatment of AD within an observational, non-interventional study. Methodology/Principal Findings 36 patients with severe, chronic AD resisting long term disease control with local corticosteroids were included. Treatment consisted of one cycle of 5 consecutive blue light-irradiations (28.9 J/cm2). Patients were instructed to ask for treatment upon disease exacerbation despite interval therapy with topical corticosteroids. The majority of patients noted first improvements after 2–3 cycles. The EASI score w…

MaleSkin PhysiologyAnatomy and PhysiologyLightmedicine.medical_treatmentlcsh:MedicinePediatric DermatologyAntigen Processing and RecognitionAtopic DermatitisDiseasePediatricsQuality of lifeYoung adultlcsh:ScienceSkinMultidisciplinarymedicine.diagnostic_testT CellsAllergy and HypersensitivityPhysicsElectromagnetic RadiationPhotodermatology and Skin AgingImmunosuppressionAtopic dermatitisMiddle Agedmedicine.anatomical_structureTreatment OutcomePatient SatisfactionObservational StudiesMedicineFemaleWhole-Body IrradiationResearch ArticleAdultmedicine.medical_specialtyLangerhans cellClinical Research DesignImmune CellsImmunologyColorDermatologyDermatitis AtopicYoung AdultUltraviolet RadiationBiopsymedicineHumansSerologic TestsBiologybusiness.industrylcsh:Rmedicine.diseaseDermatologyClinical trialImmune SystemChronic DiseaseQuality of Lifelcsh:QClinical ImmunologybusinessPloS one
researchProduct

5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety

2020

Androgenetic alopecia (AGA) is a multifactorial disease that carries a significant psychological burden with it. Dihydrotestosterone, the main pathogenic androgen in AGA, is produced by conversion of testosterone, which is catalyzed by the 5-alpha reductase (5-AR) isoenzyme family. Finasteride and dutasteride are inhibitors of these enzymes. Finasteride, which is a single receptor 5-alpha reductase inhibitor (5-ARI), acts by blocking dihydrotestosterone (DHT). Dutasteride, a dual receptor DHT blocker, has a higher potency than its predecessor, finasteride. This review corroborates the evidence of superiority of dutasteride over finasteride, and its comparable safety profile concerning ferti…

medicine.drug_classDermatologyReductasePharmacology030207 dermatology & venereal diseases03 medical and health sciences5 Alpha-Reductase Inhibitorchemistry.chemical_compound5-alpha Reductase Inhibitors0302 clinical medicinemedicineHumansTestosteronebusiness.industryFinasterideNeurotoxicityAlopeciaAndrogen AntagonistsGeneral MedicineDutasterideDutasteridemedicine.diseaseAndrogenchemistry030220 oncology & carcinogenesisDihydrotestosteroneFinasteridebusinessmedicine.drugDermatologic Therapy
researchProduct

β2Integrin deficiency yields unconventional double-negative T cells distinct from mature classical natural killer T cells in mice

2009

Expressed on leucocytes, beta(2) integrins (CD11/CD18) are specifically involved in leucocyte function. Using a CD18-deficient (CD18(-/-)) mouse model, we here report on their physiological role in lymphocyte differentiation and trafficking. CD18(-/-) mice present with a defect in the distribution of lymphocytes with highly reduced numbers of naïve B and T lymphocytes in inguinal and axillary lymph nodes. In contrast, cervical lymph nodes were fourfold enlarged harbouring unconventional T-cell receptor-alphabeta (TCR-alphabeta) and TCR-gammadelta CD3(+) CD4(-) CD8(-) (double-negative; DN) T cells that expanded in situ. Using adoptive transfer experiments, we found that these cells did not h…

MaleReceptors Antigen T-Cell alpha-betaT cellImmunologyCD1chemical and pharmacologic phenomenaBiologyLymphocyte ActivationImmunophenotypingMiceInterleukin 21T-Lymphocyte SubsetsImmune TolerancemedicineAnimalsImmunology and AllergyCytotoxic T cellIL-2 receptorAntigen-presenting cellLungLymphatic DiseasesMice KnockoutB-LymphocytesZAP70Receptors Antigen T-Cell gamma-deltahemic and immune systemsOriginal ArticlesNatural killer T cellAdoptive TransferMolecular biologyCoculture TechniquesChemotaxis Leukocytemedicine.anatomical_structureLiverCD18 AntigensImmunologyNatural Killer T-CellsFemaleLymph NodesLymphocyte Culture Test MixedImmunology
researchProduct

Targeting cells of the immune system: mannosylated HPMA–LMA block-copolymer micelles for targeting of dendritic cells

2016

Background: Successful tumor immunotherapy depends on the induction of strong and sustained tumor antigen-specific immune responses by activated antigen-presenting cells (APCs) such as dendritic cells (DCs). Since nanoparticles have the potential to codeliver tumor-specific antigen and DC-stimulating adjuvant in a DC-targeting manner, we wanted to assess the suitability of mannosylated HPMA-LMA block polymers for immunotherapy. Materials & methods: Fluorescence-labeled block copolymer micelles derived from P(HPMA)-block-P(LMA) copolymers and according statistical copolymers were synthesized via RAFT polymerization, and loaded with the APC activator L18-MDP. Both types of copolymers wer…

Materials sciencePolymersSurface Propertiesmedicine.medical_treatmentBiomedical EngineeringMedicine (miscellaneous)Bone Marrow CellsBioengineering02 engineering and technologyDevelopment01 natural sciencesMicellePolymerizationImmune systemAntigenmedicineHumansGeneral Materials ScienceReversible addition−fragmentation chain-transfer polymerizationMicelles010405 organic chemistryDendritic CellsImmunotherapyDendritic cell021001 nanoscience & nanotechnologyMolecular biology0104 chemical sciencesCell biologyMethacrylatesNanoparticlesImmunotherapy0210 nano-technologyAcetylmuramyl-Alanyl-IsoglutamineMannoseAdjuvantSpleenMannose receptorNanomedicine
researchProduct

Prävention im Alter durch Risikovermeidung, Früherkennung und frühe Behandlung

2019

Der wichtigste Risikofaktor fur Brustkrebs ist bei Frauen und Mannern das Alter. Brustkrebs beim Mann ist selten; Untersuchungen zur Fruherkennung werden deshalb nicht empfohlen; diese sind nur bei Veranderungen oder Beschwerden erforderlich (S3-Leitlinie Diagnostik 2018). Fur Frauen liegt das Lebenszeitrisiko fur Brustkrebs bei 12,8 %, d. h. dass jede achte Frau im Verlauf ihres Lebens an Brustkrebs erkrankt. Selten tritt Brustkrebs bei Frauen unter 30 Jahren auf. Der groste Teil der Frauen erkrankt zwischen dem 50. und 70. Lebensjahr; Mitte 60 ist das Risiko am hochsten. Etwa 37 % erkranken nach dem 70. Lebensjahr; Brustkrebs kann jedoch noch bis ins hohe Alter von 90 Jahren und mehr auft…

researchProduct

Platelet-Derived GARP Induces Peripheral Regulatory T Cells—Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis

2020

Platelets have been recently described as an important component of the innate and adaptive immunity through their interaction with immune cells. However, information on the platelet&ndash

0301 basic medicineCancer Researchmedicine.medical_treatmentT cellanimal diseaseschemical and pharmacologic phenomenathrombocytosisBiologylcsh:RC254-282Article03 medical and health sciences0302 clinical medicineImmune systemGARPDownregulation and upregulationmedicinemelanomaPlateletIL-2 receptorFOXP3Immunotherapybiochemical phenomena metabolism and nutritionAcquired immune systemlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensTreg030104 developmental biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisplateletsCancer researchbacteriaCancers
researchProduct

Serum S100B levels correlate with clinical benefit in a metastatic melanoma patient treated by CTLA-4 blockade: a case report.

2013

<b><i>Background:</i></b> Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is an immunoregulatory molecule expressed by activated T cells. In patients with metastatic melanoma, anti-CTLA-4 antibody therapy with ipilimumab achieves durable cancer regression in approximately 10-15% of patients. In the face of complex and sometimes delayed tumor response patterns, prognostic and predictive biomarkers are needed to monitor therapy outcomes and to identify early potential long-term survivors who might also benefit from therapy re-induction. <b><i>Case Report:</i></b> The clinical case of a 49-year-old male patient with metastatic melanoma and u…

MaleCancer ResearchMetastatic melanomamedicine.drug_classmedicine.medical_treatmentStatistics as TopicAntineoplastic AgentsS100 Calcium Binding Protein beta SubunitMonoclonal antibodySensitivity and SpecificitymedicineBiomarkers TumorCytotoxic T cellHumansCTLA-4 AntigenMelanomabusiness.industryMelanomaAntibodies MonoclonalReproducibility of ResultsHematologyImmunotherapyMiddle Agedmedicine.diseaseIpilimumabBlockadeTreatment OutcomeOncologyCTLA-4Cancer researchBiomarker (medicine)businessOnkologie
researchProduct

Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment.

2019

The incidence of allergic diseases has increased over the past 50 years, likely due to environmental factors. However, the nature of these factors and the mode of action by which they induce the type 2 immune deviation characteristic of atopic diseases remain unclear. It has previously been reported that dietary sodium chloride promotes the polarization of T helper 17 (T(H)17) cells with implications for autoimmune diseases such as multiple sclerosis. Here, we demonstrate that sodium chloride also potently promotes T(H)2 cell responses on multiple regulatory levels. Sodium chloride enhanced interleukin-4 (IL-4) and IL-13 production while suppressing interferon-gamma (IFN-gamma) production i…

0303 health sciencesNaive T cellSodiumT cellCellchemistry.chemical_elementGeneral MedicineAtopic dermatitismedicine.disease03 medical and health sciences0302 clinical medicinemedicine.anatomical_structurechemistryNFAT5InterferonImmunologymedicineTranscription factor030304 developmental biology030215 immunologymedicine.drug
researchProduct

Platelet-neutrophil aggregates promote skin pathology in psoriasis

2019

AbstractPsoriasis is a frequent systemic inflammatory autoimmune disease characterized primarily by skin lesions with massive infiltration of leukocytes but frequently also presents with cardiovascular comorbidities. Especially polymorphonuclear neutrophils (PMNs) abundantly infiltrate psoriatic skin but the cues that prompt PMNs to home to the skin are not well defined. To identify PMN surface receptors that may explain PMN skin homing in psoriasis patients, we screened 332 surface antigens on primary human blood PMNs from healthy donors and psoriasis patients. We identified platelet surface antigens as a defining feature of psoriasis PMNs, due to a significantly increased aggregation of n…

Autoimmune diseaseAntigenbusiness.industryIn vivoPsoriasisImmunologymedicinePlateletDiseasemedicine.diseasebusinessReceptorInfiltration (medical)
researchProduct

Discontinuation of braf/mek-directed targeted therapy after complete remission of metastatic melanoma : a retrospective multicenter adoreg study

2021

The advent of BRAF/MEK inhibitors (BRAFi/MEKi) has significantly improved progression-free (PFS) and overall survival (OS) for patients with advanced BRAF-V600-mutant melanoma. Long-term survivors have been identified particularly among patients with a complete response (CR) to BRAF/MEK-directed targeted therapy (TT). However, it remains unclear which patients who achieved a CR maintain a durable response and whether treatment cessation might be a safe option in these patients. Therefore, this study investigated the impact of treatment cessation on the clinical course of patients with a CR upon BRAF/MEK-directed-TT. We retrospectively selected patients with BRAF-V600-mutant advanced non-res…

0301 basic medicineOncologyadvanced melanomaCancer Researchmedicine.medical_specialtymedicine.medical_treatmentMedizin610ArticleTargeted therapycomplete response03 medical and health sciences0302 clinical medicinedisease progressionInternal medicineMedicineddc:610second-line immunotherapyneoplasmsComplete responseRC254-282business.industryMelanomaNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasetargeted therapyDiscontinuation030104 developmental biologyOncologyTumor progression030220 oncology & carcinogenesisToxicityCohortSkin cancerbusinessdiscontinuation
researchProduct

A shared tumor-antigen RNA-lipoplex vaccine with/without anti-PD1 in patients with checkpoint-inhibition experienced melanoma.

2020

3136 Background: Cancer vaccines are considered unsuitable for patients with advanced tumours and have not been clinically successful. Methods: Lipo-MERIT is an ongoing phase 1/2 trial (NCT02410733) with melanoma FixVac, a liposomal RNA vaccine targeting four non-mutant shared tumour-associated antigens (TAAs) (MAGE-A3, NY-ESO-1, tyrosinase, TPTE). Patients with stage IIIB-C and IV melanoma are eligible. The trial comprises 7 dose escalation and 3 dose expansion cohorts, the latter with FixVac alone or combined with anti-PD1. Eight doses of FixVac are administered i.v. weekly/bi-weekly followed by optional continued monthly treatment. This abstract summarizes the findings of an exploratory…

Cancer Researchbusiness.industryMelanomaImmune checkpoint inhibitorsCancerRNAmedicine.diseaseTumor antigen03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisCancer researchMedicineIn patientbusinessAnti pd1030215 immunologyLipoplexJournal of Clinical Oncology
researchProduct

CD40-Activated B Cells Migrate Towards Secondary Lymphoid Organs And Interact Dynamically With T Cells

2010

TransplantationCD40biologybusiness.industrybiology.proteinMedicineHematologybusinessSecondary lymphoid organsCell biologyBiology of Blood and Marrow Transplantation
researchProduct

IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma

2017

0301 basic medicinebusiness.industryMelanomaMutantPhases of clinical researchHematologyFirst in humanmedicine.disease03 medical and health sciences030104 developmental biologyOncologyCancer researchMedicinebusinessAnnals of Oncology
researchProduct

Complications of botulinum toxin and fillers: A narrative review

2019

Background Cosmetic surgery and esthetic procedures have become a billion dollar industry owing to the ever-growing demand of the population to stay young. The injectable treatments including fillers and botulinum toxin have become highly popular because of their quick, predictable and lasting results in the management of facial wrinkles and rejuvenation. Although these treatment modalities are relatively safe, they are associated with certain side effects. Aims In this review, we will focus on the complications of fillers and botulinum toxin. Patients/methods The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by se…

medicine.medical_specialtyEcchymosisPopulationMEDLINEFacial MusclesCosmetic TechniquesDermatologyPain ProceduralInjections030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDermal FillersHumansMedicineBotulinum Toxins Type AeducationIntensive care medicineAdverse effecteducation.field_of_studybusiness.industryBotulinum toxinInjection Site ReactionClinical trialFacial AsymmetryNeuromuscular Agents030220 oncology & carcinogenesisBrow ptosisNarrative reviewEyebrowsmedicine.symptombusinessmedicine.drugJournal of Cosmetic Dermatology
researchProduct

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up

2019

Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.

medicine.medical_specialtybusiness.industryIncidence (epidemiology)MEDLINEDermatologyDiseasemedicine.disease3. Good health030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineCarcinomaProfessional associationBasal cell carcinomaDisease management (health)Intensive care medicineRisk assessmentbusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Review of biologics in allergic contact dermatitis

2020

The resistant and recalcitrant nature of severe allergic contact dermatitis (ACD) makes its management challenging. With advances in the understanding of the cellular and molecular pathogenesis of ACD, newer therapeutic targets are becoming apparent. In particular, the use of biologics has gained momentum, given the specificity of their action. This article aims to review the presently available data on the use of biologics in ACD. English-language-based literature available on the use of biological therapy was thoroughly probed in the following databases as on October 14, 2019: PubMed, Google Scholar, The Cochrane library, Embase, Scopus, and EBSCO. The following keywords were used: "conta…

medicine.medical_specialtyDermatologyOmalizumabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineUstekinumabmedicineAdalimumabHumansImmunology and Allergy030212 general & internal medicineAllergic contact dermatitisBiological Productsbusiness.industryPatch Testsmedicine.diseaseDermatologyDupilumabInfliximabTreatment OutcomeDermatitis Allergic ContactSecukinumabbusinessmedicine.drugContact Dermatitis
researchProduct

Density of conjugated antibody determines the extent of Fc receptor dependent capture of nanoparticles by liver sinusoidal endothelial cells

2021

Despite considerable progress in the design of multifunctionalized nanoparticles (NPs) that selectively target specific cell types, their systemic application often results in unwanted liver accumulation. The exact mechanisms for this general observation are still unclear. Here we asked whether the number of cell-targeting antibodies per NP determines the extent of NP liver accumulation and also addressed the mechanisms by which antibody-coated NPs are retained in the liver. We used polysarcosine-based peptobrushes (PBs), which in an unmodified form remain in the circulation for >24 h due to the absence of a protein corona formation and low unspecific cell binding, and conjugated them with …

Biodistributionbiologymedicine.diagnostic_testChemistryCellGeneral EngineeringFc receptorGeneral Physics and AstronomyEndothelial CellsDendritic cellReceptors FcFlow cytometryCell biologymedicine.anatomical_structureLiverbiology.proteinmedicineSystemic administrationNanoparticlesGeneral Materials ScienceTissue DistributionAntibodyReceptor
researchProduct

Factors accelerating recurrences and secondary tumors in cutaneous squamous cell carcinoma

2020

To investigate factors that affect and also decrease the duration for recurrences and secondary tumors in cSCC. A retrospective study was conducted for all patients who were treated for a cSCC of the head and neck between 2009 and 2016. Anamnestic as well as epidemiological and histological data were noted and correlated with the occurrence of recurrences and secondary cancers. The duration between surgery and these events was used to determine if histological factors accelerate their occurrence. The highest risk for recurrences was seen in patients with previous skin cancers (RR 3.23). Histological ulceration (p = 0.003) and grading (p = 0.031) of the tumor were found as significant factor…

Oncologymedicine.medical_specialtySkin NeoplasmsCutaneous squamous cell carcinoma03 medical and health sciences0302 clinical medicineRisk FactorsSurgical oncologyInternal medicineEpidemiologymedicineTumor GradingHumansStage (cooking)Grading (tumors)Retrospective Studiesbusiness.industryRetrospective cohort study030206 dentistryOtorhinolaryngologyHead and Neck Neoplasms030220 oncology & carcinogenesisCarcinoma Squamous CellSurgerySecondary tumorsNeoplasm Recurrence LocalOral SurgerybusinessJournal of Cranio-Maxillofacial Surgery
researchProduct

CD11b Regulates Fungal Outgrowth but Not Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

2019

Abstract Background and Aims: In immunosuppressed individuals Aspergillus (A.) fumigatus is a frequent cause of invasive pulmonary aspergillosis (IPA) which is highly associated with relevant morbidity and mortality. Moreover, it often occurs in patients suffering from leukocyte-adhesion deficiency type 1 (LAD1) which is triggered by a functional loss of CD18 in ß2 integrin receptors as these receptors consist of an alpha subunit (CD11a-CD11d) and CD18 as the common beta subunit. ß2 integrin receptors are differentially expressed by leukocytes, and are required for cell-cell interaction, transendothelial migration, uptake of opsonized pathogens, and cell signaling processes. Here, we asked …

lcsh:Immunologic diseases. AllergyChemokineNeutrophilsPhagocytosisImmunology610 MedizinMedizinMacrophage-1 AntigenCD18InflammationKaplan-Meier EstimateBronchoalveolar LavageBiochemistryMicrobiologyAspergillus fumigatusProinflammatory cytokinecomplement receptor 3MicePhagocytosis610 Medical sciencesmedicineAnimalspneumoniaCC-chemokine ligand 5LungOriginal ResearchInflammationInvasive Pulmonary AspergillosisMice KnockoutCD11b Antigenbiologymedicine.diagnostic_testAspergillus fumigatusCD11bpolymorphonuclear neutrophilsCell BiologyHematologybiology.organism_classificationMice Inbred C57BLDisease Models AnimalBronchoalveolar lavageNeutrophil InfiltrationIntegrin alpha Mβ2 integrinsbiology.proteinCytokinesFemalemedicine.symptomlcsh:RC581-607
researchProduct

Zwei Brüder mit Papillomatosis confluens et reticularis.

2016

DermatologyJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
researchProduct

Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunothera…

2018

Abstract Therapeutic vaccination with tumor antigen-encoding RNAs is being investigated in various clinical trials. Typically, the RNA vaccine is administered intradermally, subcutaneously or intranodally with the intention to get expression of the encoded antigens in local antigen-presenting cells (APCs). We have developed a novel class of RNA-lipoplex (RNA(LIP)) immunotherapeutics for intravenous application, which allow systemic targeting of APCs. RNA(LIP) is a novel nanoparticulate formulation of lipid-complexed mRNA which selectively delivers the functional mRNA to APCs in lymphoid compartments body-wide for efficient mRNA uptake and expression of the encoded antigen by APCs. Moreover,…

0301 basic medicineCancer Researchbusiness.industrymedicine.medical_treatmentMelanomaImmunogenicityImmunotherapymedicine.diseaseVaccination03 medical and health sciences030104 developmental biology0302 clinical medicineImmune systemOncologyAntigen030220 oncology & carcinogenesisImmunologyMedicineCancer vaccinebusinessAdjuvantCancer Research
researchProduct

Vaccination with trifunctional nanoparticles that address CD8+ dendritic cells inhibits growth of established melanoma

2016

Aim: We wanted to assess the potency of a trifunctional nanoparticle (NP) that targeted and activated CD8+ dendritic cells (DC) and delivered an antigen to induce antitumor responses. Materials & methods: The DC targeting and activating properties of ferrous NPs conjugated with immunostimulatory CpG-oligonucleotides, anti-DEC205 antibody and ovalbumin (OVA) as a model antigen to induce antigen-specific T-cell responses and antitumor responses were analyzed. Results: OVA-loaded NP conjugated with immunostimulatory CpG-oligonucleotides and anti-DEC205 antibody efficiently targeted and activated CD8+ DC in vivo, and induced strong OVA-specific T-cell activation. Vaccination of B16/OVA tum…

0301 basic medicineMaterials sciencebiologyBiomedical EngineeringMedicine (miscellaneous)BioengineeringDendritic cellDevelopmentMolecular biology03 medical and health sciencesCTL*Ovalbumin030104 developmental biology0302 clinical medicineAntigenIn vivoCancer researchbiology.proteinGeneral Materials ScienceAntibodyNanocarriersCD8030215 immunologyNanomedicine
researchProduct

The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment

2021

Simple Summary Immunotherapy improved the therapeutic landscape for patients with advanced cancer diseases. However, many patients do not benefit from immunotherapy. The bidirectional crosstalk between myeloid-derived suppressor cells (MDSC) and regulatory T cells (Treg) contributes to immune evasion, limiting the success of immunotherapy by checkpoint inhibitors. This review aims to outline the current knowledge of the role and the immunosuppressive properties of MDSC and Treg within the tumor microenvironment (TME). Furthermore, we will discuss the importance of the functional crosstalk between MDSC and Treg for immunosuppression, issuing particularly the role of cell adhesion molecules. …

0301 basic medicineCancer Researchmedicine.medical_treatmentT cellCellReviewBiologylcsh:RC254-282regulatory T cellscrosstalk03 medical and health sciencestumor immune evasion0302 clinical medicinecell–cell contactmedicinetumor microenvironmentReceptorCD18Tumor microenvironmentCell adhesion moleculeImmunotherapylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmyeloid-derived suppressor cells<b>Keywords: </b>myeloid-derived suppressor cellsCrosstalk (biology)030104 developmental biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisβ2 integrinsMyeloid-derived Suppressor CellCancer researchimmunotherapyCD11Cancers
researchProduct

Multifaceted contributions of epidermal langerhans cells to cutaneous carcinogenesis.

2015

Cutaneous squamous cell carcinoma (SCC) is the most prevalent invasive malignancy with metastatic potential. The epidermis is exposed to a variety of environmental DNA-damaging chemicals, principal among which are polyaromatic hydrocarbons (PAH) ubiquitous in the environment, tobacco smoke, and broiled meats. Langerhans cells (LC) comprise a network of dendritic cells situated adjacent to basal, suprabasal, and follicular infundibular keratinocytes that when mutated can give rise to SCC, and LC-intact mice are markedly more susceptible than LC-deficient mice to chemical carcinogenesis provoked by initiation with the model PAH, 7,12-dimethylbenz[a]anthracene (DMBA). LC rapidly internalize an…

Skin Neoplasmsintegumentary systemCarcinogenesisCYP1B1Cell BiologyDermatologyMetabolismBiologymedicine.disease_causeBiochemistryArticlebody regionsPolyaromatic hydrocarbonCytochrome p450 enzymeBiochemistryLangerhans CellsmedicineCancer researchCarcinoma Squamous CellAnimalsCarcinogenesisMolecular BiologyMutagensThe Journal of investigative dermatology
researchProduct

Abstract CT022: IVAC® MUTANOME - A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma

2016

Abstract One of the hallmarks of cancer is the inherent instability of the genome leading to multiple genomic alterations and epigenetic changes that ultimately drive carcinogenesis. These processes lead to a unique molecular profile of every given tumor and to substantial intratumoral heterogeneity of cancer tissues. Recently, a series of independent reports revealed that pre-formed neoantigen specific T-cell responses are of crucial relevance for the clinical efficacy of immune checkpoint inhibitors. However, spontaneous immune recognition of neoantigens seems to be a rare event with only less than 1% of mutations inducing a T-cell response in the tumor-bearing patient. Accordingly, only …

OncologyCancer Researchmedicine.medical_specialtyMutationbusiness.industryImmunogenicityMelanomaCancermedicine.diseasemedicine.disease_causeClinical trialThe Hallmarks of CancerOncologyInternal medicineImmunologymedicineCancer vaccinebusinessCarcinogenesisCancer Research
researchProduct

549 An RNA-lipoplex (RNA-LPX) vaccine demonstrates strong immunogenicity and promising clinical activity in a Phase I trial in cutaneous melanoma pat…

2021

BackgroundLipo-MERIT is an ongoing, first-in-human, open-label, dose-escalation Phase I trial investigating safety, tolerability and immunogenicity of BNT111 in patients with advanced melanoma. BNT111 is an RNA-LPX vaccine targeting the melanoma tumor-associated antigens (TAAs) New York esophageal squamous cell carcinoma 1 (NY-ESO-1), tyrosinase, melanoma-associated antigen 3 (MAGE-A3), and transmembrane phosphatase with tensin homology (TPTE). A previous exploratory interim analysis showed that BNT111, alone or combined with immune checkpoint inhibition (CPI), has a favorable adverse event (AE) profile, gives rise to antigen-specific T-cell responses and induces durable objective responses…

PharmacologyOncologyCancer Researchmedicine.medical_specialtybusiness.industryImmunogenicityELISPOTMelanomaImmunologyInterim analysismedicine.diseaseVaccinationOncologyTolerabilityInternal medicineCutaneous melanomamedicineMolecular MedicineImmunology and AllergyAdverse effectbusinessJournal for ImmunoTherapy of Cancer
researchProduct

Systemic immunosuppression in times of COVID‐19: Do we need to rethink our standards?

2020

Summary The current SARS‐CoV‐2 pandemic particularly endangers older people with pre‐existing cardiopulmonary and metabolic conditions. However, it is also currently under discussion whether patients under immunosuppressive therapy also have a higher risk of suffering a severe course of the COVID‐19 disease. In principle though, there is currently no data available for a general reduction or pause of immunosuppression in patients with autoimmune diseases because of the SARS‐CoV‐2 pandemic. However, since there is currently neither an effective therapy nor corresponding vaccination protection, the indication for a prolonged immunosuppressive therapy should be made with special care. In parti…

medicine.medical_specialtymedicine.medical_treatment610 MedizinDiseaseReviewDermatologyAntiviral Agents030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineChloroquine610 Medical sciencesPandemicMedicineHumansIntensive care medicineImmunosuppression Therapybusiness.industryCOVID-19HydroxychloroquineImmunosuppressionChloroquineCOVID-19 Drug TreatmentCalcineurinVaccinationDoxycyclineRituximabbusinessmedicine.drugHydroxychloroquineJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes

2021

Abstract The incidence of coronavirus disease 2019 (COVID-19)-related skin manifestations has progressively grown, in parallel with the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreading. The available evidence indicates that cutaneous signs are heterogeneous and can be divided as follows: a) erythematous rashes, b) lesions of vascular origin, c) vesicular rashes, d) urticarial rashes, and e) acute generalized exanthematous pustulosis (AGEP), erythema multiforme (EM) and other polymorphic/atypical reactions. Most cutaneous manifestations appear simultaneously or after respiratory and/or systemic symptoms such as fever, even if rarely urticaria has been reported as…

medicine.medical_specialtycutaneous manifestationscutaneous manifestationbusiness.industrySARS-CoV-2COVID-19DermatologyDiseaseReviewmedicine.diseaseAcute generalized exanthematous pustulosisDermatologyVirusHypersensitivity reactionImmune systemmedicineskin rashesErythema multiformeRespiratory systemChilblainsbusiness
researchProduct

Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation in…

2010

Background Dendritic cells (DCs) constitute an attractive target for immunotherapeutic approaches. Because DCs are largely refractory to transfection with plasmid DNA, several viral transduction protocols were established. The potential side-effects of lentiviral transduction on the phenotype and activation state of DCs left unstimulated after transduction have not been assessed. There is a need to analyse these parameters as a result of the requirement of using DCs with a low activation state for therapeutic strategies intended to induce tolerance. Methods Lentivirally-transduced bone marrow (BM)-derived DCs (LV-DCs) in comparison with mock-transduced (Mock-DCs) and untreated DCs were anal…

medicine.medical_treatmentT cellGenetic enhancementT-Lymphocyteschemical and pharmacologic phenomenaBiologyLymphocyte ActivationTransduction (genetics)MiceStress PhysiologicalTransduction GeneticDrug DiscoveryGeneticsmedicineAnimalsMolecular BiologyGenetics (clinical)Mice Inbred BALB CInterleukinhemic and immune systemsImmunotherapyTransfectionDendritic CellsCell biologyInterleukin-10Mice Inbred C57BLInterleukin 10Cytokinemedicine.anatomical_structureImmunologyDermatitis Allergic ContactMolecular MedicineFemaleImmunotherapyGenetic EngineeringThe journal of gene medicine
researchProduct

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

2017

T cells directed against mutant neo-epitopes drive cancer immunity. However, spontaneous immune recognition of mutations is inefficient. We recently introduced the concept of individualized mutanome vaccines and implemented an RNA-based poly-neo-epitope approach to mobilize immunity against a spectrum of cancer mutations. Here we report the first-in-human application of this concept in melanoma. We set up a process comprising comprehensive identification of individual mutations, computational prediction of neo-epitopes, and design and manufacturing of a vaccine unique for each patient. All patients developed T cell responses against multiple vaccine neo-epitopes at up to high single-digit p…

0301 basic medicineMultidisciplinarybiologybusiness.industryMelanomaT cellmedicine.medical_treatmentCancerImmunotherapymedicine.diseaseVaccination03 medical and health sciences030104 developmental biologymedicine.anatomical_structureImmunityImmunologymedicineCancer researchbiology.proteinAntibodyNivolumabbusinessNature
researchProduct

Combination therapy of recalcitrant severe psoriasis with psoriatic arthritis, diabetes nephropathy, and liver cirrhosis

2021

Objective Treatment of recalcitrant moderate-to-severe psoriasis can be challenging. Combination therapy of biologics and immunosuppressive agents can be a new strategy for treating therapy-resistant cases with comorbidities, where many systemic medications are contraindicated. Case presentation We report a case of a 62-year-old diabetic man with a 30-year history of severe plaque psoriasis and psoriatic arthritis with cirrhosis and diabetic nephropathy that was treated successfully in combination with apremilast and etanercept after multiple previous unsuccessful treatment attempts. Conclusion There are no data supporting the combination of apremilast and etanercept in the management of re…

Liver CirrhosisMalemedicine.medical_specialtyCombination therapy610 MedizinDermatologyEtanerceptEtanerceptNephropathyDiabetic nephropathyPsoriatic arthritis610 Medical sciencesPsoriasisDiabetes MellitusmedicineHumansPsoriasisDiabetic Nephropathiesbusiness.industryArthritis PsoriaticMiddle Agedmedicine.diseaseDermatologyGuselkumabApremilastbusinessmedicine.drugJournal of Cosmetic Dermatology
researchProduct

Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Mali…

2021

Immune checkpoint inhibitors (ICI) significantly improved the prognosis of advanced melanoma patients. However, many patients do not derive long-term benefit from ICI therapy due to primary and acquired resistance. In this regard, it has been shown that coagulation factors contribute to cancer immune evasion and might therefore promote resistance to ICI. In particular, recent observations in murine systems demonstrated that myeloid-derived factor Xa (FXa) impedes anti-tumor immunity in the tumor microenvironment and that the oral FXa inhibitor (FXa-i) rivaroxaban synergizes with ICI. The synergistic effect of FXa inhibitors with clinical ICI therapy is unknown. We performed a retrospective …

Oncologyadvanced melanomaCancer Researchmedicine.medical_specialtymedicine.drug_mechanism_of_actionmedicine.medical_treatmentFactor Xa Inhibitorfactor Xa inhibitorsanti-tumor immunityArticleimmune checkpoint inhibitorsInternal medicinemedicineProgression-free survivalanticoagulationRC254-282thromboembolic eventsRivaroxabanbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancerRetrospective cohort studyImmunotherapymedicine.diseaseOncologyConcomitantimmunotherapythromboprophylaxisbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugCohort studyCancers
researchProduct

LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Re…

2021

&lt;b&gt;&lt;i&gt;Background:&lt;/i&gt;&lt;/b&gt; Hidradenitis suppurativa (HS) is a chronic, inflammatory, burdensome skin disease where medical first-line treatment is still limited to long-term, topical and/or systemic antibiotics. The RELIEVE study aimed at evaluating the efficacy of LAight® therapy – a combination of intense pulsed light and radiofrequency – as an adjunct treatment to first-line therapies in Hurley stage I and II HS. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; The RELIEVE study was performed as a two-period multicenter randomized controlled trial with blinded assessment. For period A from week 0 to week 16, the 88 participating subjects were randomized into either a…

medicine.medical_specialtymedicine.medical_treatmentDermatologyIntense pulsed lightSeverity of Illness Indexlaw.inventionRandomized controlled trialQuality of lifelawInternal medicineClinical endpointMedicineHumansHidradenitis suppurativabusiness.industryClindamycinClindamycinmedicine.diseaseTreatment efficacyAnti-Bacterial AgentsHidradenitis SuppurativaTreatment OutcomeTopical clindamycinChronic DiseaseQuality of Lifebusinessmedicine.drugDermatology (Basel, Switzerland)
researchProduct

Solidarity and transparency against the COVID ‐19 pandemic

2020

2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)business.industryDeveloped CountriesInternational CooperationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralCOVID-19DermatologyGeneral MedicinePublic administrationTransparency (behavior)SolidarityPandemicHumansMedicineLettersCoronavirus InfectionsbusinessDelivery of Health CareDeveloping CountriesPandemicsDermatologic Therapy
researchProduct

Increased frequencies of CD11b+CD33+CD14+HLA-DRlowmyeloid-derived suppressor cells are an early event in melanoma patients

2014

Myeloid-derived suppressor cells (MDSC) are a heterogeneous cell population characterized by immunosuppressive activity. Elevated levels of MDSC in peripheral blood are found in inflammatory diseases as well as in malignant tumors where they are supposed to be major contributors to mechanisms of tumor-associated tolerance. We investigated the frequency and function of MDSC in peripheral blood of melanoma patients and observed an accumulation of CD11b(+) CD33(+) CD14(+) HLA-DR(low) MDSC in all stages of disease (I-IV), including early stage I patients. Disease progression and enhanced tumor burden did not result in a further increase in frequencies or change in phenotype of MDSC. By investig…

Skin Neoplasmsmedicine.medical_treatmentCD14Sialic Acid Binding Ig-like Lectin 3CD33PopulationLipopolysaccharide ReceptorsReceptors Antigen T-CellDermatologyBiologyLymphocyte ActivationT-Lymphocytes RegulatoryBiochemistryImmune toleranceTetanus ToxoidHLA-DRmedicineHumansMyeloid CellsLymphocyte CounteducationMelanomaMolecular BiologyCells CulturedCell ProliferationNeoplasm Stagingeducation.field_of_studyCD11b AntigenMelanomaInterleukin-8HLA-DR AntigensImmunotherapymedicine.diseaseCoculture TechniquesTumor BurdenCase-Control StudiesImmunologyDisease ProgressionLeukocytes MononuclearMyeloid-derived Suppressor CellTumor EscapeExperimental Dermatology
researchProduct

Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF)

2019

BACKGROUND Hidradenitis suppurativa is a chronic inflammatory disease with high burden. Treatment options are often unsatisfactory. We assessed the effect of a combination therapy of intense pulsed light (IPL) and radiofrequency (RF). METHODS The explorative study included 47 patients and was performed as a prospective, monocentric, randomized, three-arm parallel-group design trial with a prior 12 weeks observation period. Treatment arms were IPL and RF monotherapies or IPL + RF combination therapy. After 12 weeks, all patients received IPL + RF for additional 12 weeks (cross-over). Primary endpoint was the change in active lesion numbers, secondary endpoint the change in Dermatology Qualit…

AdultMalemedicine.medical_specialtyCombination therapymedicine.medical_treatmentDermatologyIntense pulsed lightChronic inflammatory diseaseLesionYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineCombined treatmentmedicineClinical endpointHumansHidradenitis suppurativaProspective Studies030203 arthritis & rheumatologybusiness.industryIntense Pulsed Light TherapyTreatment optionsMiddle AgedRadiofrequency Therapymedicine.diseaseCombined Modality TherapyDermatologyHidradenitis SuppurativaTreatment OutcomeQuality of LifeFemalesense organsmedicine.symptombusinessJournal of Dermatological Treatment
researchProduct

Solution Properties and Potential Biological Applications of Zwitterionic Poly(ε-N-methacryloyl-l-lysine)

2013

Poly(e-N-methacryloyl-l-lysine) (PMALys) was synthesized by free radical polymerization yielding a zwitterionic polymer with Mw = 721 000 g mol–1. The polymer dissolves in pure water as well as in aqueous salt solution up to 5 M NaClO4 and over wide range of pH values (1.3 ≤ pH ≤ 12.7) as single chains without any sign for aggregate formation. The zwitterionic polymer shows an expanded random coil structure at and close to isoelectric conditions and further expands upon addition of acid and base, respectively. The polymer fulfills four major prerequisites for a promising nano carrier in potential biomedical applications: (1) It is biocompatible, indicated by a low cytotoxicity. (2) It does …

chemistry.chemical_classificationAqueous solutionPolymers and PlasticsChemistryOrganic ChemistryLysineRadical polymerizationPolymerRandom coilInorganic ChemistryIsoelectric pointPolymer chemistryMaterials ChemistryAcid–base reactionCytotoxicityMacromolecules
researchProduct

Selective RAR agonists for acne vulgaris: A narrative review.

2019

Background Acne vulgaris is a chronic disfiguring inflammatory disease of adolescents and adults affecting up to 90% of the population around the world. The sequence of etiopathogenesis in acne is not completely understood but involves abnormalities in sebum production, follicular plugging, proliferation of propionibacterium acnes, and chronic inflammation. Aims This review aims to summarize the features of the topical selective RAR agonists in treating acne vulgaris with a special emphasis on the 4th generation topical retinoid trifarotene. Methods Studies were identified by searching electronic databases (MEDLINE and PubMed) till August 2019 and reference lists of respective articles. Onl…

medicine.medical_specialtymedicine.drug_classReceptors Retinoic AcidPopulationTretinoinDermatologyAdministration Cutaneous030207 dermatology & venereal diseases03 medical and health sciencesPropionibacterium acnesRetinoids0302 clinical medicineMaintenance therapyTazaroteneAdapaleneAcne VulgarisMedicineHumansRetinoidAdapaleneeducationAcneRandomized Controlled Trials as Topiceducation.field_of_studybiologybusiness.industryNicotinic Acidsbiology.organism_classificationmedicine.diseaseDermatologyTreatment OutcomeTolerability030220 oncology & carcinogenesisDermatologic Agentsbusinessmedicine.drugJournal of cosmetic dermatologyREFERENCES
researchProduct

Efficacy of 595- and 1319-nm pulsed dye laser in the treatment of acne vulgaris: a narrative review

2020

Acne is one of the commonest problems of adolescence with almost half of the patients experiencing persistence into adulthood. Pulsed dye lasers (PDL) with wavelengths of 585 and 595 nm targeting hemoglobin have been used for the treatment of this condition and its sequelae. Recent introduction of PDL with a higher wavelength of 1319 nm has been reported to offer some benefit to acne patients. We reviewed the literature on the use of 595-nm and 1319-nm PDL in the management of acne. A PubMed literature search for search terms "pulsed dye laser," "acne laser therapy," "light therapy for acne," "595 nm and acne," "1319 nm and acne" was done. Studies, series and case reports were included. The…

AdolescentLasers DyeLasers Solid-StateDermatologylaw.inventionPulsed dye030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinestomatognathic systemlawAcne VulgarisHumansMedicineAcneDye laserbusiness.industryLasermedicine.diseaseTreatment OutcomePhotochemotherapy030220 oncology & carcinogenesisOptoelectronicsSurgeryNarrative reviewLaser TherapybusinessJournal of Cosmetic and Laser Therapy
researchProduct

Reconstitution of Myelomonocyte-Depleted Mice With Monocytes, But Not With Neutrophils, Reestablishes Arterial Hypertension and Oxidative Stress in R…

2011

0303 health sciencesmedicine.medical_specialty030309 nutrition & dieteticsbusiness.industry030302 biochemistry & molecular biologymedicine.disease_causemedicine.diseaseBiochemistry03 medical and health sciencesEndocrinologyPhysiology (medical)Pathophysiology of hypertensionInternal medicinemedicinebusinessMyelomonocyteOxidative stressFree Radical Biology and Medicine
researchProduct

Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy.

2011

Background Humanized murine models comprise a new tool to analyze novel therapeutic strategies for allergic diseases of the intestine. Objective In this study we developed a human PBMC–engrafted murine model of allergen-driven gut inflammation and analyzed the underlying immunologic mechanisms. Methods Nonobese diabetic (NOD)– scid -γc −/− mice were injected intraperitoneally with human PBMCs from allergic donors together with the respective allergen or not. Three weeks later, mice were challenged with the allergen orally or rectally, and gut inflammation was monitored with a high-resolution video miniendoscopic system, as well as histologically. Results Using the aeroallergens birch or gra…

CD4-Positive T-LymphocytesAllergymedicine.medical_treatmentImmunologyHistamine AntagonistsAdministration OralInflammationNodMice SCIDPlatelet Membrane GlycoproteinsBiologymedicine.disease_causeImmunoglobulin ELymphocyte ActivationReceptors G-Protein-Coupledchemistry.chemical_compoundMiceAllergenimmune system diseasesAdministration RectalAntibody Specificityotorhinolaryngologic diseasesmedicineHypersensitivityImmunology and AllergyAnimalsHumansColitisMice KnockoutReceptors IgEAllergensImmunoglobulin Emedicine.diseaseDisease Models AnimalCytokinechemistryGastritisImmunologybiology.proteinLeukocytes MononuclearCytokinesPollenmedicine.symptomHistamineSpleenThe Journal of allergy and clinical immunology
researchProduct

Treatment of Axillary hyperhidrosis

2022

BACKGROUND Axillary hyperhidrosis characterized by excessive sweating in the axillary regions is a frustrating chronic autonomic disorder leading to social embarrassment, impaired quality of life and usually associated with palmoplantar hyperhidrosis. Identifying the condition and its cause is central to the management. AIM The aim of this article is to discuss treatment options for axillary hyperhidrosis. METHODS Comprehensive literature search using PubMed and Google Scholar was performed to review relevant published articles related to diagnosis and treatment of axillary hyperhidrosis. RESULTS Treatment modalities for axillary hyperhydrosis vary from topical and systemic agents to inject…

medicine.medical_specialtybusiness.industry610 MedizinTreatment optionsSweating610 Medicine & healthDermatologyAutonomic disorderAxillary hyperhidrosismedicine.diseaseDermatologySweat GlandsTreatment OutcomeQuality of lifeTreatment modality610 Medical sciencesAxillaQuality of LifemedicineHumansHyperhidrosis610 Medicine &amp; healthbusinessPalmoplantar hyperhidrosisPatient educationJournal of Cosmetic Dermatology
researchProduct

Gram-positive bacteria on grass pollen exhibit adjuvant activity inducing inflammatory T cell responses.

2011

BACKGROUND: Recently, it has been established that pollen grains contain Th2-enhancing activities besides allergens. OBJECTIVE: The aim of this study was to analyse whether pollen carry additional adjuvant factors like microbes and what immunological effects they may exert. METHODS: Timothy pollen grains were collected and disseminated on agar plates, and the growing microorganisms were cultivated and defined. Furthermore, the immunologic effects of microbial products on DC and T cell responses were analysed. RESULTS: A complex mixture of bacteria and moulds was detected on grass pollen. Besides Gram-negative bacteria that are known to favour Th1-directed immune responses, moulds were ident…

LipopolysaccharideT cellGram-positive bacteriaImmunologyBiologymedicine.disease_causeGram-Positive BacteriaLymphocyte ActivationMicrobiologychemistry.chemical_compoundImmune systemTh2 CellsAdjuvants ImmunologicBacillus cereusPollenotorhinolaryngologic diseasesmedicineImmunology and AllergyHumansInflammationfood and beveragesFOXP3Rhinitis Allergic SeasonalCell DifferentiationDendritic CellsTh1 Cellsbiology.organism_classificationFlow CytometryCulture Mediamedicine.anatomical_structurechemistryPhleumImmunologyPollenTh17 CellsCD80BacteriaBacillus subtilisClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
researchProduct

Chronic venous insufficiency, cardiovascular disease, and mortality: a population study

2021

Abstract Aims  Evidence regarding the health burden of chronic venous insufficiency (CVI), its clinical determinants, and impact on outcome is scarce. Methods and results  Systematic phenotyping of CVI according to established CEAP (Clinical-Etiologic-Anatomic-Pathophysiologic) classification was performed in 12 423 participants (age range: 40–80 years) of the Gutenberg Health Study from April 2012 to April 2017. Prevalence was calculated age- and sex-specifically. Multivariable Poisson regression models were calculated to evaluate the relation of CVI with cardiovascular comorbidities. Survival analyses were carried out to assess the CVI-associated risk of death. Replication of findings was…

medicine.medical_specialtyChronic venous insufficiencyEpidemiologyPopulationMECHANISMSInternal medicineEpidemiologymedicineVARICOSE-VEINSeducationRISKeducation.field_of_studybusiness.industryHazard ratioWOMENChronic venous insufficiencyASSOCIATIONmedicine.diseaseCardiovascular diseaseAll-cause mortalityComorbidityPREGNANCYATHEROSCLEROSISCohortPopulation studySurgeryCardiology and Cardiovascular MedicinebusinessCohort studyEuropean Heart Journal
researchProduct

Editorial: Update Guidelines Dermatologic Oncology

2013

medicine.medical_specialtyDermatologic Oncologybusiness.industryMEDLINEMedicineDermatologybusinessDermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Selective Uptake of Cylindrical Poly(2-Oxazoline) Brush-AntiDEC205 Antibody-OVA Antigen Conjugates into DEC-Positive Dendritic Cells and Subsequent T…

2014

To achieve specific cell targeting by various receptors for oligosaccharides or antibodies, a carrier must not be taken up by any of the very many different cells and needs functional groups prone to clean conjugation chemistry to derive well-defined structures with a high biological specificity. A polymeric nanocarrier is presented that consists of a cylindrical brush polymer with poly-2-oxazoline side chains carrying an azide functional group on each of the many side chain ends. After click conjugation of dye and an anti-DEC205 antibody to the periphery of the cylindrical brush polymer, antibody-mediated specific binding and uptake into DEC205(+) -positive mouse bone marrow-derived dendri…

ImmunoconjugatesOvalbuminPolymersT-LymphocytesT cellMolecular Sequence DataReceptors Cell SurfacePeptideLymphocyte ActivationCatalysisMinor Histocompatibility AntigensMicechemistry.chemical_compoundAntigenAntigens CDmedicineSide chainAnimalsLectins C-TypeAmino Acid SequenceReceptorOxazolesCells Culturedchemistry.chemical_classificationbiologyOrganic ChemistryDendritic CellsGeneral Chemistrymedicine.anatomical_structurechemistryBiochemistrybiology.proteinBiophysicsAzideAntibodyConjugateChemistry - A European Journal
researchProduct

Sodium chloride is an ionic checkpoint for human Th2 cell responses and shapes the atopic skin microenvironment

2018

One sentence summarySodium is an ionic checkpoint for the induction and amplification of human Th2 cell responses and shapes the atopic skin microenvironment, where it could serve as a novel therapeutic target for Th2 mediated diseases.AbstractThere has been a strong increase in the incidence of allergic diseases over the last 50 years. Environmental factors most likely account for this phenomenon. However, the nature of these factors and the mode of action by which they induce the type 2 immune deviation, which is characteristic of atopic diseases, remains unclear. It has previously been reported that dietary sodium chloride promotes the polarization of Th17 cells with implications for aut…

Naive T cellChemistryKinaseEffectorT cellSodiumCellchemistry.chemical_elementAtopic dermatitismedicine.diseasemedicine.anatomical_structureImmunologymedicineTranscription factor
researchProduct

Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma

2016

The development of nucleic acid based vaccines against cancer has gained considerable momentum through the advancement of modern sequencing technologies and on novel RNA-based synthetic drug formats, which can be readily adapted following identification of every patient's tumor-specific mutations. Furthermore, affordable and individual ‘on demand’ production of molecularly optimized vaccines should allow their application in large groups of patients. This has resulted in the therapeutic concept of an active personalized cancer vaccine, which has been brought into clinical testing. Successful trials have been performed by intranodal administration of sterile isotonic solutions of synthetic …

0301 basic medicineDrugmedicine.medical_treatmentmedia_common.quotation_subjectBiomedical EngineeringMedicine (miscellaneous)Bioengineering02 engineering and technologyComputational biologyDevelopmentPharmacologyCancer VaccinesExcipients03 medical and health sciencesAntigens NeoplasmmedicineAnimalsHumansGeneral Materials ScienceRNA MessengerPrecision MedicineMelanomamedia_commonClinical Trials as TopicMessenger RNAbusiness.industryRNAImmunotherapy021001 nanoscience & nanotechnologyTumor antigenNanomedicine030104 developmental biologyLiposomesDrug deliveryNucleic acidNanoparticlesRNAImmunotherapyCancer vaccine0210 nano-technologybusinessNanomedicine
researchProduct

Immune checkpoint inhibitors: a milestone in the treatment of melanoma

2016

Summary It has been known for decades that the immune system is able to detect and destroy tumor cells. In the past, this knowledge – mostly acquired through animal experiments – could not be used to benefit our patients, because immuno-oncological therapeutic approaches in humans had constantly failed over recent decades. With the exception of adjuvant interferon therapy, none of these approaches had found its way into everyday clinical practice, and only very few patients were able to enjoy long-term survival associated with good quality of life. With the advent of novel immunological approaches, the meaning of long-term survival as well as quality of life has been redefined for oncologic…

Oncologymedicine.medical_specialtybusiness.industryMelanomamedicine.medical_treatmentDermatologyImmunotherapymedicine.diseaseReview article030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Immune system030220 oncology & carcinogenesisInternal medicineImmunologyMilestone (project management)medicineAdverse effectbusinessAdjuvantJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Immunotherapy of Malignant Melanoma

2014

For the field of cancer immunotherapy, malignant melanoma has a very special role. It has certainly critically influenced the past and the present of the field. Research performed in malignant melanoma has started to shape the field of cancer immunotherapy more than 20 years ago with the discovery of the first tumor-associated antigens documented to be recognized by antigen-specific T cells in patients. As discussed in the following sections, the privileged role of malignant melanoma has not been restricted to the pioneering phase of initial antigen discovery but has continued to exist through more than 20 years as documented by the clinical successes reported for immunotherapies such as cy…

Oncologymedicine.medical_specialtybusiness.industryMelanomamedicine.medical_treatmentIpilimumabImmunotherapymedicine.diseaseTumor antigenOncolytic virusAntigenCancer immunotherapyInternal medicinemedicineIn patientbusinessmedicine.drug
researchProduct

New diagnostic and imaging technologies in dermatology

2021

INTRODUCTION Diagnosis of dermatological disorders is primarily based on clinical examination in combination with histopathology. However, clinical findings alone may not be sufficient for accurate diagnosis and cutaneous biopsies are being associated with morbidity. OBJECTIVE The objective of this article is to review the newer technologies along with their applications, limitation and future prospectus. METHODOLOGY Comprehensive literature search was performed using electronic online databases "PubMed" and "Google Scholar". Articles published in English language were considered for the review. RESULTS In order to improve and/or widen the armamentarium in dermatologic disease diagnosis and…

medicine.medical_specialtyDiagnostic methodsMicroscopy Confocalbusiness.industryEmerging technologies610 MedizinEnglish languageDermatologyDermatologyArtificial Intelligence610 Medical sciencesMedicineHigh frequency ultrasonographyHumansDermatological disordersbusinessTomography Optical CoherenceUltrasonography
researchProduct

Merkel cell carcinoma‐derived Erysipelas carcinomatosum

2019

medicine.medical_specialtySkin NeoplasmsMerkel cell carcinomabusiness.industryDermatologyGeneral Medicinemedicine.diseaseDermatologyErysipelasCarcinoma Merkel CellErysipelasmedicineHumansbusinessDermatologic Therapy
researchProduct

Psoriasis: Embarking a dynamic shift in the skin microbiota

2021

Recent interest has arisen regarding the role of microbiome and its composition in the pathogenesis of psoriasis. Numerous studies have shown that there are alterations in skin flora arrangement between normal individuals and psoriatic patients. Psoriasis exacerbation could be interconnected with epidermal or mucosal colonization with streptococci, Malassezia, Staphylococcus aureus, or Candida albicans. The role of cutaneous and gut microbiome in psoriasis pathogenesis has recently been studied in both human and animal models. In this review, we try to evaluate various pathogenic mechanisms linking the microbiota and psoriasis. The literature research included peer-reviewed articles which i…

medicine.medical_specialtyExacerbation610 MedizinMEDLINESkin floraDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine610 Medical sciencesPsoriasisCandida albicansmedicineAnimalsHumansPsoriasisMicrobiomeCandida albicansSkinMalasseziabiologybusiness.industryMicrobiotabiology.organism_classificationmedicine.diseaseDermatologyClinical trial030220 oncology & carcinogenesisMalasseziabusinessJournal of Cosmetic Dermatology
researchProduct

Carboxytherapy in dermatology.

2022

Abstract Carboxytherapy is a medical technique during which a sterile gas—carbon dioxide—is injected into the subdermal tissue. The utility of carbon dioxide injections has enhanced the practical relevance of carboxytherapy as a method for the management of multiple disorders. We have evaluated its use in the treatment of dermatologic conditions by searching electronic databases (ie, MEDLINE and PubMed) for contributions in the English language through January 2021. Carboxytherapy provides an attractive aesthetic option in skin rejuvenation, atrophic scars, striae distensae (stretch marks), cellulite-fibrolipodystrophy adhesions after liposuction, and certain types of alopecia. We discuss t…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentMEDLINEAtrophic scarsEnglish languageDermatologyCarbon Dioxidemedicine.diseaseDermatologyMultiple disordersStretch marksLiposuctionmedicineStriae distensaeHumansmedicine.symptomCellulitebusinessStriae DistensaeRejuvenationSkinClinics in dermatology
researchProduct

Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.

2012

Aims Dipeptidyl peptidase-4 (DPP-4) inhibitors are a novel class of drugs for the treatment of hyperglycaemia. Preliminary evidence suggests that their antioxidant and anti-inflammatory effects may have beneficial effects on the cardiovascular complications of diabetes. In the present study, we investigate in an experimental sepsis model whether linagliptin exerts pleiotropic vascular effects independent of its glucose-lowering properties. Methods and results Linagliptin (83 mg/kg chow for 7days) was administered in a rat model of lipopolysaccharide (LPS) (10 mg/kg, single i.p. dose/24 h)-induced sepsis. Vascular relaxation, reactive oxygen species (ROS) formation, expression of NADPH oxida…

LipopolysaccharidesMalemedicine.medical_specialtyPhysiologyNeutrophilsAdministration OralVasodilationLinagliptinBiologyLinagliptinAntioxidantsProinflammatory cytokineSepsisPhysiology (medical)Internal medicineSepsismedicineLeukocytesAnimalsHumansEndothelial dysfunctionRats WistarDipeptidyl peptidase-4Respiratory BurstDipeptidyl-Peptidase IV InhibitorsNADPH oxidasemedicine.diseaseRespiratory burstRatsVasodilationOxidative StressEndocrinologyPurinesbiology.proteinQuinazolinesCardiology and Cardiovascular MedicineDiabetic Angiopathiesmedicine.drugCardiovascular research
researchProduct

Brief S2k guidelines - Cutaneous squamous cell carcinoma

2013

medicine.medical_specialtyText miningCutaneous squamous cell carcinomabusiness.industryMEDLINECarcinomaMedicineDermatologybusinessmedicine.diseaseDermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Nanoparticles and the immune system: challenges and opportunities

2016

Chemistrymedicine.medical_treatmentBiomedical EngineeringMedicine (miscellaneous)Bioengineering02 engineering and technologyDevelopment010402 general chemistry021001 nanoscience & nanotechnology01 natural sciences0104 chemical sciencesImmune toleranceImmune systemCancer immunotherapyImmune SystemNeoplasmsImmunologyImmune TolerancemedicineNanoparticlesGeneral Materials ScienceImmunotherapy0210 nano-technologyNanomedicine
researchProduct

Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels

2020

To target nanomedicines to specific cells, especially of the immune system, nanobodies can be considered as an attractive tool, as they lack the Fc part as compared to traditional antibodies and, thus, prevent unfavorable Fc-receptor mediated mistargeting. For that purpose, we have site-specifically conjugated CD206/MMR-targeting nanobodies to three types of dye-labeled nanogel derivatives: non-degradable nanogels, acid-degradable nanogels (with ketal crosslinks), and single polymer chains (also obtained after nanogel degradation). All of them can be obtained from the same reactive ester precursor block copolymer. After incubation with na&iuml

0301 basic medicineEndosomeNanogels02 engineering and technologyConjugated systemArticleM2 macrophage03 medical and health sciencesHumansReversible addition−fragmentation chain-transfer polymerizationlcsh:QH301-705.5targetingchemistry.chemical_classificationRAFT polymerizationChinese hamster ovary cellGeneral MedicinePolymerHydrogen-Ion Concentrationmultivalency021001 nanoscience & nanotechnologynanobody030104 developmental biologyTAMchemistryCD206lcsh:Biology (General)nanogelclick chemistryClick chemistryBiophysicsNanocarriers0210 nano-technologyNanogelCells
researchProduct

Emerging drugs for the treatment of vitiligo.

2020

Introduction: Vitiligo is a relatively common autoimmune depigmenting disorder of the skin. There has been a great advance in understanding the pathological basis, which has led to the development and utilization of various new molecules in treating vitiligo. This review aims at a comprehensively describing the treatments available and the emerging treatment aspects and the scope for future developments.Areas covered: This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treat…

MAP Kinase Signaling SystemAdministration TopicalVitiligoAdministration OralVitiligoBiologicsBioinformatics030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineClinical Trials Phase II as TopicLocalized vitiligoMedicineHumansJanus Kinase InhibitorsPharmacology (medical)skin and connective tissue diseasesRandomized Controlled Trials as TopicPharmacologytreatmentintegumentary systembusiness.industrymedicine.diseaseCombined Modality TherapyJAK inhibitorchemistryClinical Trials Phase III as Topic030220 oncology & carcinogenesisCytokinesAfamelanotideDermatologic AgentsbusinessJanus kinaseBiologics; JAK inhibitor; treatment; vitiligoExpert opinion on emerging drugs
researchProduct

Simvastatin in vitiligo: an update with recent review of the literature.

2021

Patients with vitiligo often seek medical attention, as it diminishes their quality of life resulting in significant morbidity. Several topical and systemic therapies are in vogue targeting the immunological aspect of this disease, but results are often unsatisfactory, and complete cure remains elusive. Recently, simvastatin, a 3-hydroxy-3-methylyglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, is being evaluated for vitiligo management because of its multimodal action, easy availability, and low cost. The proposed multimodal actions range from anti-inflammatory, antioxidant, to immunomodulatory properties which may be of therapeutic benefit in vitiligo patients. The authors intend to eva…

medicine.medical_specialtySimvastatinintegumentary systembusiness.industryVitiligoDermatologyDiseaseVitiligomedicine.disease030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeSimvastatin030220 oncology & carcinogenesismedicineQuality of LifeHumansHydroxymethylglutaryl-CoA Reductase Inhibitorsskin and connective tissue diseasesIntensive care medicinebusinessMedical attentionmedicine.drugInternational journal of dermatologyReference
researchProduct

Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilities.

2015

The introduction of small molecule BRAFV600 kinase inhibitors represents a milestone in the targeted therapy of patients with metastatic melanoma by a significant increase in therapeutic efficacy in terms of overall and progression-free survival compared with conventional chemotherapy. Beside BRAFV600 inhibitor treatment, radiotherapy is a further mainstay for the therapy of metastatic melanoma and thus a concomitant or sequential application of BRAFV600 inhibitors and radiotherapy is inevitable. Recent reports show a significant radiosensitization of the irradiated healthy tissue in patients with melanoma after the combination of radiotherapy and BRAFV600 inhibitors, evoking concern in cl…

OncologyProto-Oncogene Proteins B-rafCancer Researchmedicine.medical_specialtyBRAF inhibitormedicine.medical_treatmentRadiation ToleranceTargeted therapy030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinemedicineCombined Modality TherapyHumansVemurafenibneoplasmsMelanomaProtein Kinase Inhibitorsbusiness.industryMelanomaDabrafenibGeneral Medicinemedicine.diseaseCombined Modality TherapyRadiation therapyOncology030220 oncology & carcinogenesisConcomitantMutationbusinessmedicine.drugFuture oncology (London, England)
researchProduct

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

2016

Lymphoid organs, in which antigen presenting cells (APCs) are in close proximity to T cells, are the ideal microenvironment for efficient priming and amplification of T-cell responses. However, the systemic delivery of vaccine antigens into dendritic cells (DCs) is hampered by various technical challenges. Here we show that DCs can be targeted precisely and effectively in vivo using intravenously administered RNA-lipoplexes (RNA-LPX) based on well-known lipid carriers by optimally adjusting net charge, without the need for functionalization of particles with molecular ligands. The LPX protects RNA from extracellular ribonucleases and mediates its efficient uptake and expression of the encod…

Male0301 basic medicineLymphoid TissueT-Lymphocytesmedicine.medical_treatmentStatic ElectricityPriming (immunology)BiologyLymphocyte ActivationAutoantigensCancer VaccinesMice03 medical and health sciences0302 clinical medicineAntigenCancer immunotherapyAntigens NeoplasmInterferonmedicineAnimalsHumansAntigen-presenting cellAntigens ViralMelanomaAntigen PresentationDrug CarriersMembrane GlycoproteinsMultidisciplinaryInnate immune systemClinical Trials Phase I as TopicEffectorMacrophagesRNADendritic CellsMice Inbred C57BLDisease Models Animal030104 developmental biologyToll-Like Receptor 7030220 oncology & carcinogenesisInterferon Type IImmunologyCancer researchNanoparticlesRNAAdministration IntravenousFemaleImmunotherapymedicine.drugNature
researchProduct

Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells

2011

Background Administration of interferon-α (IFN-α) represents an approved adjuvant therapy as reported for malignancies like melanoma and several viral infections. In malignant diseases, tolerance processes are critically involved in tumor progression. In this study, the effect of IFN-α on tolerance induction by human tolerogenic dendritic cells (DC) was analyzed. We focussed on tolerogenic IL-10-modulated DC (IL-10 DC) that are known to induce anergic regulatory T cells (iTregs). Methodology/Principal Findings IFN-α promoted an enhanced maturation of IL-10 DC as demonstrated by upregulation of the differentiation marker CD83 as well as costimulatory molecules. IFN-α treatment resulted in an…

Immune CellsT cellImmunologylcsh:MedicineAntigen-Presenting CellsPriming (immunology)Adaptive ImmunityBiologyLymphocyte ActivationImmune SuppressionT-Lymphocytes RegulatoryImmunophenotypingImmune toleranceImmune ActivationImmunomodulationImmune TolerancemedicineHumansCytotoxic T celllcsh:ScienceAntigen-presenting cellBiologyImmune ResponseClonal AnergyMultidisciplinaryClonal anergyT Cellslcsh:RImmunityImmunoregulationInterferon-alphaCell DifferentiationDendritic CellsInterleukin-10Tolerance inductionmedicine.anatomical_structureImmune SystemImmunologyCancer researchCytokineslcsh:QImmunizationCD8Research ArticlePLoS ONE
researchProduct

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients

2018

Background: Concomitant radiation with BRAF inhibitor (BRAFi) therapy may increase radiation-induced side effects but also potentially improve tumour control in melanoma patients. Methods: A total of 155 patients with BRAF-mutated melanoma from 17 European skin cancer centres were retrospectively analysed. Out of these, 87 patients received concomitant radiotherapy and BRAFi (59 vemurafenib, 28 dabrafenib), while in 68 patients BRAFi therapy was interrupted during radiation (51 vemurafenib, 17 dabrafenib). Overall survival was calculated from the first radiation (OSRT) and from start of BRAFi therapy (OSBRAFi). Results: The median duration of BRAFi treatment interruption prior to radiothera…

0301 basic medicineOncologyMaleCancer ResearchRadiation-Sensitizing AgentsSkin Neoplasmsmedicine.medical_treatmentMedizinCohort Studies0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsOximesVemurafenibProspective cohort studyMelanomaAged 80 and overMelanomaImidazolesMiddle AgedTreatment OutcomeOncology030220 oncology & carcinogenesisFemalemedicine.drugAdultProto-Oncogene Proteins B-rafmedicine.medical_specialtyAdolescentDrug Administration ScheduleBRAF03 medical and health sciencesYoung AdultInternal medicinemedicineHumansddc:610dabrafenibProtein Kinase InhibitorsradiotherapyAgedRetrospective Studiesbusiness.industryDabrafenibRetrospective cohort studymedicine.diseaseRadiation therapyradiation030104 developmental biologyVemurafenibConcomitantClinical StudySkin cancerbusinessBritish Journal of Cancer
researchProduct

Acanthosis nigricans: A review.

2020

Background Acanthosis nigricans (AN) is a cutaneous disorder characterized by symmetric velvety hyperpigmented plaques on intertriginous areas like axilla, neck, inframammary, and groin. Aims To summarize the pathophysiology and classification of AN, provide an update of diagnostic testing strategies, and describe the current therapeutic options described so far in the literature for this disease. Methods A comprehensive english language literature search across multiple databases (PubMed, EMBASE, MEDLINE, and Cochrane) for keywords (alone and in combination) was performed. MeSH as well as non-MeSH terms such as "acanthosis nigricans," "classification," "pathophysiology," "diagnosis," "trea…

medicine.medical_specialtyKeratolyticMEDLINEDermatologyDiseaseIntertriginous030207 dermatology & venereal diseases03 medical and health sciencesRetinoids0302 clinical medicinemedicineInframammary foldHumansAcanthosis NigricansObesityVitamin DAcanthosis nigricansbusiness.industrymedicine.diseaseDermatologyAxillamedicine.anatomical_structure030220 oncology & carcinogenesisChemical peelingInsulin ResistancebusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

Asymptomatische, erworbene symmetrische Läsionen am Augeninnenwinkel

2017

business.industryMedicineDermatologyComputational biologybusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

LFA-1 Contributes to Signal I of T-Cell Activation and to the Production of Th1 Cytokines

2010

The beta(2) integrins are important for both transendothelial migration of leukocytes and T-cell activation during antigen presentation. In T cells, triggering of leukocyte functional antigen-1 (LFA-1) is required for full activation and T-helper (Th)1/Th2 differentiation. We used CD18-deficient (CD18(-/-)) mice to examine the role of LFA-1 in the activation of T cells. Compared with wild-type controls, CD18(-/-) T cells proliferated normally when stimulated with antibodies against CD3 and CD28, but secreted significantly less IFN-gamma and IL-2 than their wild-type counterparts. However, when T cells were stimulated with dendritic cells (DCs) that provide additional LFA-1 ligation, the pro…

CD3 ComplexT cellchemical and pharmacologic phenomenaDermatologyBiologyBiochemistryAntibodiesMinor Lymphocyte Stimulatory AntigensInterferon-gammaMice03 medical and health sciencesInterleukin 210302 clinical medicineCD28 AntigensCell AdhesionmedicineAnimalsCytotoxic T cellIL-2 receptorAntigen-presenting cellMolecular Biology030304 developmental biologyMice Inbred BALB C0303 health sciencesCD40CD28Cell Differentiationhemic and immune systemsDendritic CellsCell BiologyTh1 CellsIntercellular Adhesion Molecule-1Natural killer T cellLymphocyte Function-Associated Antigen-1Mice Mutant StrainsCell biologyMice Inbred C57BLmedicine.anatomical_structureCD18 Antigensbiology.proteinInterleukin-2Cell DivisionSignal Transduction030215 immunologyJournal of Investigative Dermatology
researchProduct

Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways …

2008

Gene gun-mediated biolistic DNA vaccination with beta-galactosidase (betaGal)-encoding plasmid vectors efficiently modulated antigen-induced immune responses in an animal model of type I allergy, including the inhibition of immunoglobulin E (IgE) production. Here we show that CD4(+) as well as CD8(+) T cells from mice biolistically transfected with a plasmid encoding betaGal under the control of the fascin promoter (pFascin-betaGal) are capable of inhibiting betaGal-specific IgE production after adoptive transfer into naïve recipients. Moreover, suppression of IgE production was dependent on interferon (IFN)-gamma. To analyse the modalities of activation of CD4(+) and CD8(+) T cells regardi…

CD4-Positive T-LymphocytesCytotoxicity ImmunologicKeratinocytesAdoptive cell transferGenetic VectorsImmunologyAntigen presentationPriming (immunology)CD8-Positive T-LymphocytesBiologyImmunoglobulin GDNA vaccinationInterferon-gammaMiceCross-PrimingImmune systemAntigenHypersensitivityVaccines DNAAnimalsImmunology and AllergyCytotoxic T cellPromoter Regions GeneticMice KnockoutAntigen PresentationInterleukin-12 Subunit p40Keratin-15VaccinationT-Lymphocytes Helper-InducerOriginal ArticlesBiolisticsImmunoglobulin Ebeta-GalactosidaseAdoptive TransferMolecular biologyImmunoglobulin GLangerhans CellsImmunologybiology.proteinKeratin-5FemaleImmunology
researchProduct

Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cells.

2013

Objective— Immune cells contribute to angiotensin II (ATII)–induced vascular dysfunction and inflammation. Interferon-γ (IFN-γ), an inflammatory cytokine exclusively produced by immune cells, seems to be involved in ATII-driven cardiovascular injury, but the actions and cellular source of IFN-γ remain incompletely understood. Approach and Results— IFN-γ −/− and Tbx21 −/− mice were partially protected from ATII-induced (1 mg/kg per day of ATII, infused subcutaneously by miniosmotic pumps) vascular endothelial and smooth muscle dysfunction, whereas mice overexpressing IFN-γ showed constitutive vascular dysfunction. Absence of T-box expressed in T cells (T-bet), the IFN-γ transcription factor…

Malemedicine.medical_specialtyAdoptive cell transfermedicine.medical_treatmentInflammationBiologyMonocytesInterferon-gammaMiceRandom AllocationImmune systemReference ValuesInternal medicinemedicineAnimalsVascular DiseasesVascular recruitmentVascular tissueAortaAngiotensin IIAngiotensin IIKiller Cells NaturalMice Inbred C57BLDisease Models AnimalOxidative StressCytokineEndocrinologyInterleukin 12Endothelium Vascularmedicine.symptomCardiology and Cardiovascular MedicineArteriosclerosis, thrombosis, and vascular biology
researchProduct

Toward Anticancer Immunotherapeutics: Well-Defined Polymer-Antibody Conjugates for Selective Dendritic Cell Targeting

2014

This paper describes the synthesis of semitelechelic maleimide-modified N-(2-hydroxypropyl)methacrylamid) (HPMA) based polymers of narrow dispersity that can be conjugated e.g. to anti-DEC-205 antibodies affording "star-like" topologies (one antibody decorated with several polymer chains). FCS revealed a hydrodynamic diameter of R(h)  = 7.9 nm and SEC narrow dispersity (1.45). Primary in vitro studies with bone marrow derived dendritic cells (DC) show higher cellular binding and uptake rates compared to control samples. Moreover, incubating these conjugates to primary splenocytes demonstrates a much higher affinity to the primary DCs than to any other immune cell population within the splee…

education.field_of_studyPolymers and PlasticsbiologyStereochemistryChemistryDispersityPopulationBioengineeringDendritic cellConjugated systemIn vitroBiomaterialsMaterials ChemistryBiophysicsbiology.proteinSplenocyteAntibodyeducationBiotechnologyConjugateMacromolecular Bioscience
researchProduct

New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) fo…

2017

There has been considerable progress in treating malignant melanoma over the last few years. The immune-checkpoint-inhibitors nivolumab and pembrolizumab have been approved by the Food and Drug Administration in 2014 for the therapy of metastatic melanoma. Anti-programmed cell death-1-blocking antibodies are known to cause immune-related adverse events. Physicians should be aware of common and rare side effects and pay attention to new ones. We therefore report a severe and life-threatening side effect of anti-programmed cell death-1 immunotherapy with nivolumab that has not been previously reported: the development of a third-degree atrioventricular block. After a second infusion with nivo…

MaleUveal NeoplasmsOncologyCancer Researchmedicine.medical_specialtyMyocarditisSide effectDermatologyPembrolizumab030204 cardiovascular system & hematologyAutoimmune Diseases03 medical and health sciencesAntineoplastic Agents ImmunologicalFatal Outcome0302 clinical medicineInternal medicineHumansMedicineAtrioventricular BlockMelanomaMyositisMyositisbusiness.industryThird-degree atrioventricular blockMelanomaAntibodies MonoclonalMiddle Agedmedicine.diseaseNivolumabOncology030220 oncology & carcinogenesisImmunologyNivolumabbusinessAtrioventricular blockMelanoma Research
researchProduct

Characterizing psychosocial distress in melanoma patients using the expert rating instrument PO-Bado SF

2014

Background Although psychosocial distress has been evaluated well in cancer entities like breast or prostate cancer, its impact on melanoma patients still needs to be characterized. The objectives of this study were to (i) evaluate psychosocial distress in melanoma patients using an expert rating instrument [basic documentation for psycho-oncology short version (PO-Bado SF)]; (ii) determine associated demographic and clinical variables; and (iii) assess the acceptance of using PO-Bado SF as a routine procedure in a skin cancer unit. Methods A cross-sectional group of 696 melanoma patients was recruited. During the routine contact, doctors assessed the patients subjective distress using PO-B…

AdultMalemedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentDermatologyDiseaseProstate cancermedicineHumansMelanomaAgedAged 80 and overbusiness.industryCancerMiddle Agedmedicine.diseaseRadiation therapyDistressCross-Sectional StudiesInfectious DiseasesPhysical therapyAnxietyFemaleSkin cancermedicine.symptombusinessPsychosocialStress PsychologicalJournal of the European Academy of Dermatology and Venereology
researchProduct

Past, present and future of immunology in Mainz.

2016

0301 basic medicine03 medical and health sciences030104 developmental biologyAllergy and ImmunologyGermanyImmunologyMEDLINELibrary scienceHumansBiologyCellular immunology
researchProduct

Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF)

2019

Background: Hidradenitis suppurativa is a chronic inflammatory disease with high burden. Treatment options are often unsatisfactory. We assessed the effect of a combination therapy of intense pulsed light (IPL) and radiofrequency (RF). Methods: The explorative study included 47 patients and was performed as a prospective, monocentric, randomized, three-arm parallel-group design trial with a prior 12 weeks observation period. Treatment arms were IPL and RF monotherapies or IPL + RF combination therapy. After 12 weeks, all patients received IPL + RF for additional 12 weeks (cross-over). Primary endpoint was the change in active lesion numbers, secondary endpoint the change in Dermatology Qual…

sense organs
researchProduct